ATC Classification
- Alimentary tract and metabolism (A)
- Other alimentary tract and metabolism products (A16)
- Appetite stimulants (A15)
- Anabolic agents for systemic use (A14)
- Tonics (A13)
- Mineral supplements (A12)
- Other mineral supplements (A12C)
- Other mineral products (A12CX)
- Selenium (A12CE)
- Fluoride (A12CD)
- Magnesium (A12CC)
- Magnesium (different salts in combination) (A12CC30)
- Magnesium oxide (A12CC10)
- Magnesium orotate (A12CC09)
- Magnesium pidolate (A12CC08)
- Magnesium levulinate (A12CC07)
- Magnesium lactate (A12CC06)
- Magnesium aspartate (A12CC05)
- Magnesium citrate (A12CC04)
- Magnesium gluconate (A12CC03)
- Magnesium sulfate (A12CC02)
- Magnesium chloride (A12CC01)
- Zinc (A12CB)
- Sodium (A12CA)
- Potassium (A12B)
- Calcium (A12A)
- Calcium, combinations with vitamin d and/or other drugs (A12AX)
- Calcium (A12AA)
- Calcium laevulate (A12AA30)
- Calcium (different salts in combination) (A12AA20)
- Calcium citrate (A12AA13)
- Calcium pangamate (A12AA11)
- Calcium glucoheptonate (A12AA10)
- Calcium citrate lysine complex (A12AA09)
- Calcium glycerylphosphate (A12AA08)
- Calcium chloride (A12AA07)
- Calcium lactate gluconate (A12AA06)
- Calcium lactate (A12AA05)
- Calcium carbonate (A12AA04)
- Calcium gluconate (A12AA03)
- Calcium glubionate (A12AA02)
- Calcium phosphate (A12AA01)
- Other mineral supplements (A12C)
- Vitamins (A11)
- Other vitamin products, combinations (A11J)
- Other plain vitamin preparations (A11H)
- Other plain vitamin preparations (A11HA)
- Ascorbic acid (vitamin c), incl. combinations (A11G)
- Vitamin b-complex, incl. combinations (A11E)
- Vitamin b1, plain and in combination with vitamin b6 and b12 (A11D)
- Vitamin a and d, incl. combinations of the two (A11C)
- Multivitamins, plain (A11B)
- Multivitamins, combinations (A11A)
- Drugs used in diabetes (A10)
- Other drugs used in diabetes (A10X)
- Blood glucose lowering drugs, excl. insulins (A10B)
- Sodium-glucose co-transporter 2 (sglt2) inhibitors (A10BK)
- Glucagon-like peptide-1 (glp-1) analogues (A10BJ)
- Other blood glucose lowering drugs, excl. insulins (A10BX)
- Dipeptidyl peptidase 4 (dpp-4) inhibitors (A10BH)
- Thiazolidinediones (A10BG)
- Alpha glucosidase inhibitors (A10BF)
- Combinations of oral blood glucose lowering drugs (A10BD)
- Sitagliptin and dapagliflozin (A10BD29)
- Metformin and teneligliptin (A10BD28)
- Metformin, linagliptin and empagliflozin (A10BD27)
- Metformin and lobeglitazone (A10BD26)
- Metformin, saxagliptin and dapagliflozin (A10BD25)
- Sitagliptin and ertugliflozin (A10BD24)
- Metformin and ertugliflozin (A10BD23)
- Metformin and evogliptin (A10BD22)
- Saxagliptin and dapagliflozin (A10BD21)
- Metformin and empagliflozin (A10BD20)
- Linagliptin and empagliflozin (A10BD19)
- Metformin and gemigliptin (A10BD18)
- Metformin and acarbose (A10BD17)
- Metformin and canagliflozin (A10BD16)
- Metformin and dapagliflozin (A10BD15)
- Metformin and repaglinide (A10BD14)
- Metformin and alogliptin (A10BD13)
- Pioglitazone and sitagliptin (A10BD12)
- Metformin and linagliptin (A10BD11)
- Metformin and saxagliptin (A10BD10)
- Pioglitazone and alogliptin (A10BD09)
- Metformin and vildagliptin (A10BD08)
- Metformin and sitagliptin (A10BD07)
- Glimepiride and pioglitazone (A10BD06)
- Metformin and pioglitazone (A10BD05)
- Glimepiride and rosiglitazone (A10BD04)
- Metformin and rosiglitazone (A10BD03)
- Metformin and sulfonylureas (A10BD02)
- Phenformin and sulfonylureas (A10BD01)
- Sulfonamides (heterocyclic) (A10BC)
- Sulfonylureas (A10BB)
- Biguanides (A10BA)
- Insulins and analogues (A10A)
- Insulins and analogues for inhalation (A10AF)
- Insulins and analogues for injection, long-acting (A10AE)
- Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting (A10AD)
- Insulins and analogues for injection, intermediate-acting (A10AC)
- Insulins and analogues for injection, fast-acting (A10AB)
- Digestives, incl. enzymes (A09)
- Antiobesity preparations, excl. diet products (A08)
- Antiobesity preparations, excl. diet products (A08A)
- Other antiobesity drugs (A08AX)
- Peripherally acting antiobesity products (A08AB)
- Centrally acting antiobesity products (A08AA)
- Phentermine and topiramate (A08AA51)
- Setmelanotide (A08AA12)
- Bupropion and naltrexone (A08AA62)
- Ephedrine, combinations (A08AA56)
- Lorcaserin (A08AA11)
- Sibutramine (A08AA10)
- Mefenorex (A08AA09)
- Clobenzorex (A08AA08)
- Cathine (A08AA07)
- Etilamfetamine (A08AA06)
- Mazindol (A08AA05)
- Dexfenfluramine (A08AA04)
- Amfepramone (A08AA03)
- Fenfluramine (A08AA02)
- Phentermine (A08AA01)
- Antiobesity preparations, excl. diet products (A08A)
- Antidiarrheals, intestinal antiinflammatory/antiinfective agents (A07)
- Other antidiarrheals (A07X)
- Antidiarrheal microorganisms (A07F)
- Intestinal antiinflammatory agents (A07E)
- Antipropulsives (A07D)
- Electrolytes with carbohydrates (A07C)
- Intestinal adsorbents (A07B)
- Intestinal antiinfectives (A07A)
- Other intestinal antiinfectives (A07AX)
- Imidazole derivatives (A07AC)
- Sulfonamides (A07AB)
- Antibiotics (A07AA)
- Rifamycin (A07AA13)
- Streptomycin, combinations (A07AA54)
- Neomycin, combinations (A07AA51)
- Fidaxomicin (A07AA12)
- Rifaximin (A07AA11)
- Colistin (A07AA10)
- Vancomycin (A07AA09)
- Kanamycin (A07AA08)
- Amphotericin b (A07AA07)
- Paromomycin (A07AA06)
- Polymyxin b (A07AA05)
- Streptomycin (A07AA04)
- Natamycin (A07AA03)
- Nystatin (A07AA02)
- Neomycin (A07AA01)
- Drugs for constipation (A06)
- Drugs for constipation (A06A)
- Other drugs for constipation (A06AX)
- Peripheral opioid receptor antagonists (A06AH)
- Enemas (A06AG)
- Osmotically acting laxatives (A06AD)
- Macrogol, combinations (A06AD65)
- Lactulose, combinations (A06AD61)
- Sodium tartrate (A06AD21)
- Magnesium citrate (A06AD19)
- Sorbitol (A06AD18)
- Sodium phosphate (A06AD17)
- Mannitol (A06AD16)
- Macrogol (A06AD15)
- Pentaerithrityl (A06AD14)
- Sodium sulfate (A06AD13)
- Lactitol (A06AD12)
- Lactulose (A06AD11)
- Mineral salts in combination (A06AD10)
- Magnesium sulfate (A06AD04)
- Magnesium peroxide (A06AD03)
- Magnesium oxide (A06AD02)
- Magnesium carbonate (A06AD01)
- Bulk-forming laxatives (A06AC)
- Contact laxatives (A06AB)
- Sodium picosulfate, combinations (A06AB58)
- Cascara, combinations (A06AB57)
- Senna glycosides, combinations (A06AB56)
- Dantron, combinations (A06AB53)
- Bisacodyl, combinations (A06AB52)
- Contact laxatives in combination with belladonna alkaloids (A06AB30)
- Contact laxatives in combination (A06AB20)
- Bisoxatin (A06AB09)
- Sodium picosulfate (A06AB08)
- Cascara (A06AB07)
- Senna glycosides (A06AB06)
- Castor oil (A06AB05)
- Phenolphthalein (A06AB04)
- Dantron (A06AB03)
- Bisacodyl (A06AB02)
- Oxyphenisatine (A06AB01)
- Softeners, emollients (A06AA)
- Drugs for constipation (A06A)
- Bile and liver therapy (A05)
- Drugs for bile therapy and lipotropics in combination (A05C)
- Liver therapy, lipotropics (A05B)
- Bile therapy (A05A)
- Antiemetics and antinauseants (A04)
- Antiemetics and antinauseants (A04A)
- Other antiemetics (A04AD)
- Serotonin (5ht3) antagonists (A04AA)
- Antiemetics and antinauseants (A04A)
- Drugs for functional gastrointestinal disorders (A03)
- Propulsives (A03F)
- Antispasmodics and anticholinergics in combination with other drugs (A03E)
- Antispasmodics in combination with analgesics (A03D)
- Antispasmodics in combination with psycholeptics (A03C)
- Other antispasmodics in combination with psycholeptics (A03CC)
- Belladonna and derivatives in combination with psycholeptics (A03CB)
- Synthetic anticholinergic agents in combination with psycholeptics (A03CA)
- Propantheline and psycholeptics (A03CA34)
- Emepronium and psycholeptics (A03CA30)
- Pipenzolate and psycholeptics (A03CA09)
- Diphemanil and psycholeptics (A03CA08)
- Ambutonium and psycholeptics (A03CA07)
- Bevonium and psycholeptics (A03CA06)
- Glycopyrronium bromide and psycholeptics (A03CA05)
- Otilonium bromide and psycholeptics (A03CA04)
- Oxyphencyclimine and psycholeptics (A03CA03)
- Clidinium and psycholeptics (A03CA02)
- Isopropamide and psycholeptics (A03CA01)
- Belladonna and derivatives, plain (A03B)
- Drugs for functional gastrointestinal disorders (A03A)
- Other drugs for functional gastrointestinal disorders (A03AX)
- Menthae piperitae aetheroleum (A03AX15)
- Alverine, combinations (A03AX58)
- Trimethyldiphenylpropylamine (A03AX30)
- Valethamate (A03AX14)
- Silicones (A03AX13)
- Phloroglucinol (A03AX12)
- Caroverine (A03AX11)
- Isometheptene (A03AX10)
- Trepibutone (A03AX09)
- Alverine (A03AX08)
- Proxazole (A03AX07)
- Idanpramine (A03AX06)
- Fenoverine (A03AX05)
- Pinaverium (A03AX04)
- Chlorbenzoxamine (A03AX03)
- Diisopromine (A03AX02)
- Fenpiprane (A03AX01)
- Serotonin receptor antagonists (A03AE)
- Papaverine and derivatives (A03AD)
- Synthetic antispasmodics, amides with tertiary amines (A03AC)
- Synthetic anticholinergics, quaternary ammonium compounds (A03AB)
- Oxyphenonium, combinations (A03AB53)
- Fenpiverinium (A03AB21)
- Timepidium bromide (A03AB19)
- Prifinium bromide (A03AB18)
- Tiemonium iodide (A03AB17)
- (2-benzhydryloxyethyl)diethyl-methylammonium iodide (A03AB16)
- Diphemanil (A03AB15)
- Pipenzolate (A03AB14)
- Bevonium (A03AB13)
- Mepenzolate (A03AB12)
- Poldine (A03AB11)
- Hexocyclium (A03AB10)
- Isopropamide (A03AB09)
- Tridihexethyl (A03AB08)
- Methantheline (A03AB07)
- Otilonium bromide (A03AB06)
- Propantheline (A03AB05)
- Penthienate (A03AB04)
- Oxyphenonium (A03AB03)
- Glycopyrronium bromide (A03AB02)
- Benzilone (A03AB01)
- Synthetic anticholinergics, esters with tertiary amino group (A03AA)
- Other drugs for functional gastrointestinal disorders (A03AX)
- Drugs for acid related disorders (A02)
- Other drugs for acid related disorders (A02X)
- Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) (A02B)
- Other drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) (A02BX)
- Irsogladine (A02BX16)
- Teprenone (A02BX15)
- Rebamipide (A02BX14)
- Gefarnate, combinations with psycholeptics (A02BX77)
- Carbenoxolone, combinations with psycholeptics (A02BX71)
- Carbenoxolone, combinations excl. psycholeptics (A02BX51)
- Alginic acid (A02BX13)
- Bismuth subnitrate (A02BX12)
- Troxipide (A02BX11)
- Zolimidine (A02BX10)
- Acetoxolone (A02BX09)
- Sulglicotide (A02BX08)
- Gefarnate (A02BX07)
- Proglumide (A02BX06)
- Bismuth subcitrate (A02BX05)
- Methiosulfonium chloride (A02BX04)
- Pirenzepine (A02BX03)
- Sucralfate (A02BX02)
- Carbenoxolone (A02BX01)
- Combinations for eradication of helicobacter pylori (A02BD)
- Vonoprazan and amoxicillin (A02BD17)
- Omeprazole, amoxicillin and rifabutin (A02BD16)
- Vonoprazan, amoxicillin and metronidazole (A02BD15)
- Vonoprazan, amoxicillin and clarithromycin (A02BD14)
- Rabeprazole, amoxicillin and metronidazole (A02BD13)
- Rabeprazole, amoxicillin and clarithromycin (A02BD12)
- Pantoprazole, amoxicillin, clarithromycin and metronidazole (A02BD11)
- Lansoprazole, amoxicillin and levofloxacin (A02BD10)
- Lansoprazole, clarithromycin and tinidazole (A02BD09)
- Bismuth subcitrate, tetracycline and metronidazole (A02BD08)
- Lansoprazole, amoxicillin and clarithromycin (A02BD07)
- Esomeprazole, amoxicillin and clarithromycin (A02BD06)
- Omeprazole, amoxicillin and clarithromycin (A02BD05)
- Pantoprazole, amoxicillin and clarithromycin (A02BD04)
- Lansoprazole, amoxicillin and metronidazole (A02BD03)
- Lansoprazole, tetracycline and metronidazole (A02BD02)
- Omeprazole, amoxicillin and metronidazole (A02BD01)
- Proton pump inhibitors (A02BC)
- Omeprazole, combinations (A02BC51)
- Tegoprazan (A02BC09)
- Vonoprazan (A02BC08)
- Rabeprazole, combinations (A02BC54)
- Lansoprazole, combinations (A02BC53)
- Dexrabeprazole (A02BC07)
- Dexlansoprazole (A02BC06)
- Esomeprazole (A02BC05)
- Rabeprazole (A02BC04)
- Lansoprazole (A02BC03)
- Pantoprazole (A02BC02)
- Omeprazole (A02BC01)
- Prostaglandins (A02BB)
- H2-receptor antagonists (A02BA)
- Other drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) (A02BX)
- Antacids (A02A)
- Antacids, other combinations (A02AX)
- Antacids with sodium bicarbonate (A02AH)
- Antacids with antispasmodics (A02AG)
- Antacids with antiflatulents (A02AF)
- Combinations and complexes of aluminium, calcium and magnesium compounds (A02AD)
- Calcium compounds (A02AC)
- Aluminium compounds (A02AB)
- Magnesium compounds (A02AA)
- Stomatological preparations (A01)
- Stomatological preparations (A01A)
- Other agents for local oral treatment (A01AD)
- Corticosteroids for local oral treatment (A01AC)
- Antiinfectives and antiseptics for local oral treatment (A01AB)
- Chlorhexidine and cetylpyridinium (A01AB53)
- Oxytetracycline (A01AB25)
- Octenidine (A01AB24)
- Minocycline (A01AB23)
- Doxycycline (A01AB22)
- Chlortetracycline (A01AB21)
- Sodium perborate (A01AB19)
- Clotrimazole (A01AB18)
- Metronidazole (A01AB17)
- Mepartricin (A01AB16)
- Tibezonium iodide (A01AB15)
- Benzoxonium chloride (A01AB14)
- Tetracycline (A01AB13)
- Hexetidine (A01AB12)
- Various (A01AB11)
- Natamycin (A01AB10)
- Miconazole (A01AB09)
- Neomycin (A01AB08)
- Oxyquinoline (A01AB07)
- Domiphen (A01AB06)
- Polynoxylin (A01AB05)
- Amphotericin b (A01AB04)
- Chlorhexidine (A01AB03)
- Hydrogen peroxide (A01AB02)
- Caries prophylactic agents (A01AA)
- Stomatological preparations (A01A)
- Blood and blood forming organs (B)
- Other hematological agents (B06)
- Blood substitutes and perfusion solutions (B05)
- Hemodialytics and hemofiltrates (B05Z)
- I.v. solution additives (B05X)
- Other i.v. solution additives (B05XX)
- Vitamins (B05XC)
- Amino acids (B05XB)
- Electrolyte solutions (B05XA)
- Sodium selenite (B05XA20)
- Calcium gluconate (B05XA19)
- Zinc sulfate (B05XA18)
- Electrolytes in combination with other drugs (B05XA31)
- Combinations of electrolytes (B05XA30)
- Potassium acetate (B05XA17)
- Cardioplegia solutions (B05XA16)
- Potassium lactate (B05XA15)
- Sodium glycerophosphate (B05XA14)
- Hydrochloric acid (B05XA13)
- Zinc chloride (B05XA12)
- Magnesium chloride (B05XA11)
- Magnesium phosphate (B05XA10)
- Sodium phosphate (B05XA09)
- Sodium acetate (B05XA08)
- Calcium chloride (B05XA07)
- Potassium phosphate, incl. combinations with other potassium salts (B05XA06)
- Magnesium sulfate (B05XA05)
- Ammonium chloride (B05XA04)
- Sodium chloride (B05XA03)
- Sodium bicarbonate (B05XA02)
- Potassium chloride (B05XA01)
- Peritoneal dialytics (B05D)
- Irrigating solutions (B05C)
- Other irrigating solutions (B05CX)
- Salt solutions (B05CB)
- Antiinfectives (B05CA)
- I.v. solutions (B05B)
- Blood and related products (B05A)
- Other blood products (B05AX)
- Blood substitutes and plasma protein fractions (B05AA)
- Antianemic preparations (B03)
- Other antianemic preparations (B03X)
- Vitamin b12 and folic acid (B03B)
- Iron preparations (B03A)
- Iron in other combinations (B03AE)
- Iron in combination with folic acid (B03AD)
- Iron, parenteral preparations (B03AC)
- Iron trivalent, oral preparations (B03AB)
- Iron bivalent, oral preparations (B03AA)
- Ferrous sodium citrate (B03AA12)
- Ferrous iodine (B03AA11)
- Ferrous ascorbate (B03AA10)
- Ferrous aspartate (B03AA09)
- Ferrous tartrate (B03AA08)
- Ferrous sulfate (B03AA07)
- Ferrous succinate (B03AA06)
- Ferrous chloride (B03AA05)
- Ferrous carbonate (B03AA04)
- Ferrous gluconate (B03AA03)
- Ferrous fumarate (B03AA02)
- Ferrous glycine sulfate (B03AA01)
- Antihemorrhagics (B02)
- Vitamin k and other hemostatics (B02B)
- Other systemic hemostatics (B02BX)
- Blood coagulation factors (B02BD)
- Etranacogene dezaparvovec (B02BD16)
- Valoctocogene roxaparvovec (B02BD15)
- Thrombin (B02BD30)
- Susoctocog alfa (B02BD14)
- Coagulation factor x (B02BD13)
- Catridecacog (B02BD11)
- Von willebrand factor (B02BD10)
- Coagulation factor viia (B02BD08)
- Coagulation factor xiii (B02BD07)
- Von willebrand factor and coagulation factor viii in combination (B02BD06)
- Coagulation factor vii (B02BD05)
- Coagulation factor ix (B02BD04)
- Factor viii inhibitor bypassing activity (B02BD03)
- Coagulation factor viii (B02BD02)
- Coagulation factor ix, ii, vii and x in combination (B02BD01)
- Local hemostatics (B02BC)
- Fibrinogen (B02BB)
- Vitamin k (B02BA)
- Antifibrinolytics (B02A)
- Vitamin k and other hemostatics (B02B)
- Antithrombotic agents (B01)
- Antithrombotic agents (B01A)
- Other antithrombotic agents (B01AX)
- Direct factor xa inhibitors (B01AF)
- Direct thrombin inhibitors (B01AE)
- Enzymes (B01AD)
- Apadamtase alfa and cinaxadamtase alfa (B01AD13)
- Protein c (B01AD12)
- Tenecteplase (B01AD11)
- Drotrecogin alfa (activated) (B01AD10)
- Ancrod (B01AD09)
- Saruplase (B01AD08)
- Reteplase (B01AD07)
- Brinase (B01AD06)
- Fibrinolysin (B01AD05)
- Urokinase (B01AD04)
- Anistreplase (B01AD03)
- Alteplase (B01AD02)
- Streptokinase (B01AD01)
- Platelet aggregation inhibitors excl. heparin (B01AC)
- Limaprost (B01AC28)
- Acetylsalicylic acid, combinations with proton pump inhibitors (B01AC56)
- Combinations (B01AC30)
- Selexipag (B01AC27)
- Vorapaxar (B01AC26)
- Cangrelor (B01AC25)
- Ticagrelor (B01AC24)
- Cilostazol (B01AC23)
- Prasugrel (B01AC22)
- Treprostinil (B01AC21)
- Beraprost (B01AC19)
- Triflusal (B01AC18)
- Tirofiban (B01AC17)
- Eptifibatide (B01AC16)
- Aloxiprin (B01AC15)
- Abciximab (B01AC13)
- Iloprost (B01AC11)
- Indobufen (B01AC10)
- Epoprostenol (B01AC09)
- Carbasalate calcium (B01AC08)
- Dipyridamole (B01AC07)
- Acetylsalicylic acid (B01AC06)
- Ticlopidine (B01AC05)
- Clopidogrel (B01AC04)
- Picotamide (B01AC03)
- Cloricromen (B01AC02)
- Ditazole (B01AC01)
- Heparin group (B01AB)
- Vitamin k antagonists (B01AA)
- Antithrombotic agents (B01A)
- Cardiovascular system (C)
- Lipid modifying agents (C10)
- Lipid modifying agents, combinations (C10B)
- Lipid modifying agents in combination with other drugs (C10BX)
- Rosuvastatin and perindopril (C10BX21)
- Rosuvastatin and telmisartan (C10BX20)
- Atorvastatin, amlodipine and candesartan (C10BX19)
- Atorvastatin, amlodipine and ramipril (C10BX18)
- Rosuvastatin and ramipril (C10BX17)
- Rosuvastatin and fimasartan (C10BX16)
- Atorvastatin and perindopril (C10BX15)
- Rosuvastatin, amlodipine and perindopril (C10BX14)
- Rosuvastatin, perindopril and indapamide (C10BX13)
- Atorvastatin, acetylsalicylic acid and perindopril (C10BX12)
- Atorvastatin, amlodipine and perindopril (C10BX11)
- Rosuvastatin and valsartan (C10BX10)
- Rosuvastatin and amlodipine (C10BX09)
- Atorvastatin and acetylsalicylic acid (C10BX08)
- Rosuvastatin, amlodipine and lisinopril (C10BX07)
- Atorvastatin, acetylsalicylic acid and ramipril (C10BX06)
- Rosuvastatin and acetylsalicylic acid (C10BX05)
- Simvastatin, acetylsalicylic acid and ramipril (C10BX04)
- Atorvastatin and amlodipine (C10BX03)
- Pravastatin and acetylsalicylic acid (C10BX02)
- Simvastatin and acetylsalicylic acid (C10BX01)
- Combinations of various lipid modifying agents (C10BA)
- Pravastatin, ezetimibe and fenofibrate (C10BA12)
- Pravastatin and ezetimibe (C10BA11)
- Bempedoic acid and ezetimibe (C10BA10)
- Rosuvastatin and fenofibrate (C10BA09)
- Atorvastatin and omega-3 fatty acids (C10BA08)
- Rosuvastatin and omega-3 fatty acids (C10BA07)
- Rosuvastatin and ezetimibe (C10BA06)
- Atorvastatin and ezetimibe (C10BA05)
- Simvastatin and fenofibrate (C10BA04)
- Pravastatin and fenofibrate (C10BA03)
- Simvastatin and ezetimibe (C10BA02)
- Lovastatin and nicotinic acid (C10BA01)
- Lipid modifying agents in combination with other drugs (C10BX)
- Lipid modifying agents, plain (C10A)
- Other lipid modifying agents (C10AX)
- Volanesorsen (C10AX18)
- Evinacumab (C10AX17)
- Inclisiran (C10AX16)
- Bempedoic acid (C10AX15)
- Alirocumab (C10AX14)
- Evolocumab (C10AX13)
- Lomitapide (C10AX12)
- Mipomersen (C10AX11)
- Alipogene tiparvovec (C10AX10)
- Ezetimibe (C10AX09)
- Policosanol (C10AX08)
- Magnesium pyridoxal 5-phosphate glutamate (C10AX07)
- Omega-3-triglycerides incl. other esters and acids (C10AX06)
- Meglutol (C10AX05)
- Tiadenol (C10AX03)
- Probucol (C10AX02)
- Dextrothyroxine (C10AX01)
- Nicotinic acid and derivatives (C10AD)
- Bile acid sequestrants (C10AC)
- Fibrates (C10AB)
- Hmg coa reductase inhibitors (C10AA)
- Other lipid modifying agents (C10AX)
- Lipid modifying agents, combinations (C10B)
- Agents acting on the renin-angiotensin system (C09)
- Other agents acting on the renin-angiotensin system (C09X)
- Angiotensin ii receptor blockers (arbs), combinations (C09D)
- Angiotensin ii receptor blockers (arbs), other combinations (C09DX)
- Telmisartan, amlodipine and hydrochlorothiazide (C09DX08)
- Irbesartan, amlodipine and hydrochlorothiazide (C09DX07)
- Candesartan, amlodipine and hydrochlorothiazide (C09DX06)
- Valsartan and nebivolol (C09DX05)
- Valsartan and sacubitril (C09DX04)
- Olmesartan medoxomil, amlodipine and hydrochlorothiazide (C09DX03)
- Valsartan and aliskiren (C09DX02)
- Valsartan, amlodipine and hydrochlorothiazide (C09DX01)
- Angiotensin ii receptor blockers (arbs) and calcium channel blockers (C09DB)
- Angiotensin ii receptor blockers (arbs) and diuretics (C09DA)
- Fimasartan and diuretics (C09DA10)
- Azilsartan medoxomil and diuretics (C09DA09)
- Olmesartan medoxomil and diuretics (C09DA08)
- Telmisartan and diuretics (C09DA07)
- Candesartan and diuretics (C09DA06)
- Irbesartan and diuretics (C09DA04)
- Valsartan and diuretics (C09DA03)
- Eprosartan and diuretics (C09DA02)
- Losartan and diuretics (C09DA01)
- Angiotensin ii receptor blockers (arbs), other combinations (C09DX)
- Angiotensin ii receptor blockers (arbs), plain (C09C)
- Ace inhibitors, combinations (C09B)
- Ace inhibitors, other combinations (C09BX)
- Zofenopril and nebivolol (C09BX07)
- Perindopril, bisoprolol, amlodipine and indapamide (C09BX06)
- Ramipril and bisoprolol (C09BX05)
- Perindopril, bisoprolol and amlodipine (C09BX04)
- Ramipril, amlodipine and hydrochlorothiazide (C09BX03)
- Perindopril and bisoprolol (C09BX02)
- Perindopril, amlodipine and indapamide (C09BX01)
- Ace inhibitors and calcium channel blockers (C09BB)
- Benazepril and amlodipine (C09BB13)
- Delapril and manidipine (C09BB12)
- Trandolapril and verapamil (C09BB10)
- Ramipril and amlodipine (C09BB07)
- Enalapril and nitrendipine (C09BB06)
- Ramipril and felodipine (C09BB05)
- Perindopril and amlodipine (C09BB04)
- Lisinopril and amlodipine (C09BB03)
- Enalapril and lercanidipine (C09BB02)
- Ace inhibitors and diuretics (C09BA)
- Zofenopril and diuretics (C09BA15)
- Moexipril and diuretics (C09BA13)
- Delapril and diuretics (C09BA12)
- Fosinopril and diuretics (C09BA09)
- Cilazapril and diuretics (C09BA08)
- Benazepril and diuretics (C09BA07)
- Quinapril and diuretics (C09BA06)
- Ramipril and diuretics (C09BA05)
- Perindopril and diuretics (C09BA04)
- Lisinopril and diuretics (C09BA03)
- Enalapril and diuretics (C09BA02)
- Captopril and diuretics (C09BA01)
- Ace inhibitors, other combinations (C09BX)
- Ace inhibitors, plain (C09A)
- Ace inhibitors, plain (C09AA)
- Imidapril (C09AA16)
- Zofenopril (C09AA15)
- Temocapril (C09AA14)
- Moexipril (C09AA13)
- Delapril (C09AA12)
- Spirapril (C09AA11)
- Trandolapril (C09AA10)
- Fosinopril (C09AA09)
- Cilazapril (C09AA08)
- Benazepril (C09AA07)
- Quinapril (C09AA06)
- Ramipril (C09AA05)
- Perindopril (C09AA04)
- Lisinopril (C09AA03)
- Enalapril (C09AA02)
- Captopril (C09AA01)
- Ace inhibitors, plain (C09AA)
- Calcium channel blockers (C08)
- Calcium channel blockers and diuretics (C08G)
- Non-selective calcium channel blockers (C08E)
- Selective calcium channel blockers with direct cardiac effects (C08D)
- Selective calcium channel blockers with mainly vascular effects (C08C)
- Other selective calcium channel blockers with mainly vascular effects (C08CX)
- Dihydropyridine derivatives (C08CA)
- Levamlodipine (C08CA17)
- Amlodipine and celecoxib (C08CA51)
- Nifedipine, combinations (C08CA55)
- Clevidipine (C08CA16)
- Benidipine (C08CA15)
- Cilnidipine (C08CA14)
- Lercanidipine (C08CA13)
- Barnidipine (C08CA12)
- Manidipine (C08CA11)
- Nilvadipine (C08CA10)
- Lacidipine (C08CA09)
- Nitrendipine (C08CA08)
- Nisoldipine (C08CA07)
- Nimodipine (C08CA06)
- Nifedipine (C08CA05)
- Nicardipine (C08CA04)
- Isradipine (C08CA03)
- Felodipine (C08CA02)
- Amlodipine (C08CA01)
- Beta blocking agents (C07)
- Beta blocking agents, other combinations (C07F)
- Beta blocking agents, other combinations (C07FX)
- Beta blocking agents and calcium channel blockers (C07FB)
- Beta blocking agents and vasodilators (C07E)
- Beta blocking agents, thiazides and other diuretics (C07D)
- Beta blocking agents and other diuretics (C07C)
- Beta blocking agents and thiazides (C07B)
- Alpha and beta blocking agents and thiazides (C07BG)
- Beta blocking agents, selective, and thiazides (C07BB)
- Beta blocking agents, non-selective, and thiazides (C07BA)
- Beta blocking agents (C07A)
- Alpha and beta blocking agents (C07AG)
- Beta blocking agents, selective (C07AB)
- Beta blocking agents, non-selective (C07AA)
- Beta blocking agents, other combinations (C07F)
- Vasoprotectives (C05)
- Other vasoprotectives (C05X)
- Capillary stabilizing agents (C05C)
- Antivaricose therapy (C05B)
- Agents for treatment of hemorrhoids and anal fissures for topical use (C05A)
- Other agents for treatment of hemorrhoids and anal fissures for topical use (C05AX)
- Muscle relaxants (C05AE)
- Local anesthetics (C05AD)
- Antibiotics (C05AB)
- Corticosteroids (C05AA)
- Peripheral vasodilators (C04)
- Peripheral vasodilators (C04A)
- Other peripheral vasodilators (C04AX)
- Clazosentan (C04AX33)
- Fasudil (C04AX32)
- Azapetine (C04AX30)
- Ifenprodil (C04AX28)
- Cinepazide (C04AX27)
- Cetiedil (C04AX26)
- Visnadine (C04AX24)
- Butalamine (C04AX23)
- Naftidrofuryl (C04AX21)
- Buflomedil (C04AX20)
- Suloctidil (C04AX19)
- Vinburnine (C04AX17)
- Bencyclane (C04AX11)
- Moxisylyte (C04AX10)
- Vincamine (C04AX07)
- Phenoxybenzamine (C04AX02)
- Cyclandelate (C04AX01)
- Enzymes (C04AF)
- Ergot alkaloids (C04AE)
- Purine derivatives (C04AD)
- Nicotinic acid and derivatives (C04AC)
- Imidazoline derivatives (C04AB)
- 2-amino-1-phenylethanol derivatives (C04AA)
- Other peripheral vasodilators (C04AX)
- Peripheral vasodilators (C04A)
- Diuretics (C03)
- Other diuretics (C03X)
- Diuretics and potassium-sparing agents in combination (C03E)
- High-ceiling diuretics and potassium-sparing agents (C03EB)
- Low-ceiling diuretics and potassium-sparing agents (C03EA)
- Butizide and potassium-sparing agents (C03EA14)
- Bendroflumethiazide and potassium-sparing agents (C03EA13)
- Metolazone and potassium-sparing agents (C03EA12)
- Cyclopenthiazide and potassium-sparing agents (C03EA07)
- Chlortalidone and potassium-sparing agents (C03EA06)
- Mebutizide and potassium-sparing agents (C03EA05)
- Altizide and potassium-sparing agents (C03EA04)
- Epitizide and potassium-sparing agents (C03EA03)
- Trichlormethiazide and potassium-sparing agents (C03EA02)
- Hydrochlorothiazide and potassium-sparing agents (C03EA01)
- Aldosterone antagonists and other potassium-sparing agents (C03D)
- High-ceiling diuretics (C03C)
- Low-ceiling diuretics, excl. thiazides (C03B)
- Other low-ceiling diuretics (C03BX)
- Sulfonamides, combinations with other drugs (C03BK)
- Xanthine derivatives (C03BD)
- Mercurial diuretics (C03BC)
- Sulfonamides and potassium in combination (C03BB)
- Sulfonamides, plain (C03BA)
- Low-ceiling diuretics, thiazides (C03A)
- Thiazides, combinations with other drugs (C03AX)
- Thiazides, combinations with psycholeptics and/or analgesics (C03AH)
- Thiazides and potassium in combination (C03AB)
- Cyclothiazide and potassium (C03AB09)
- Methyclothiazide and potassium (C03AB08)
- Cyclopenthiazide and potassium (C03AB07)
- Trichlormethiazide and potassium (C03AB06)
- Polythiazide and potassium (C03AB05)
- Chlorothiazide and potassium (C03AB04)
- Hydrochlorothiazide and potassium (C03AB03)
- Hydroflumethiazide and potassium (C03AB02)
- Bendroflumethiazide and potassium (C03AB01)
- Thiazides, plain (C03AA)
- Antihypertensives (C02)
- Combinations of antihypertensives in atc-gr. c02 (C02N)
- Antihypertensives and diuretics in combination (C02L)
- Other antihypertensives and diuretics (C02LX)
- Serotonin antagonists and diuretics (C02LN)
- Mao inhibitors and diuretics (C02LL)
- Alkaloids, excl. rauwolfia, in combination with diuretics (C02LK)
- Hydrazinophthalazine derivatives and diuretics (C02LG)
- Guanidine derivatives and diuretics (C02LF)
- Alpha-adrenoreceptor antagonists and diuretics (C02LE)
- Imidazoline receptor agonists in combination with diuretics (C02LC)
- Methyldopa and diuretics in combination (C02LB)
- Rauwolfia alkaloids and diuretics in combination (C02LA)
- Reserpine and diuretics, combinations with psycholeptics (C02LA71)
- Rescinnamine and diuretics, combinations with other drugs (C02LA52)
- Reserpine and diuretics, combinations with other drugs (C02LA51)
- Combination of rauwolfia alkaloids and diuretics incl. other combinations (C02LA50)
- Syrosingopine and diuretics (C02LA09)
- Rauwolfia alkaloids, whole root and diuretics (C02LA08)
- Bietaserpine and diuretics (C02LA07)
- Methoserpidine and diuretics (C02LA04)
- Deserpidine and diuretics (C02LA03)
- Rescinnamine and diuretics (C02LA02)
- Reserpine and diuretics (C02LA01)
- Other antihypertensives (C02K)
- Arteriolar smooth muscle, agents acting on (C02D)
- Antiadrenergic agents, peripherally acting (C02C)
- Antiadrenergic agents, ganglion-blocking (C02B)
- Antiadrenergic agents, centrally acting (C02A)
- Imidazoline receptor agonists (C02AC)
- Methyldopa (C02AB)
- Rauwolfia alkaloids (C02AA)
- Bietaserpine, combinations (C02AA57)
- Combinations of rauwolfia alkoloids, combinations (C02AA53)
- Reserpine, combinations (C02AA52)
- Bietaserpine (C02AA07)
- Methoserpidine (C02AA06)
- Deserpidine (C02AA05)
- Rauwolfia alkaloids, whole root (C02AA04)
- Combinations of rauwolfia alkaloids (C02AA03)
- Reserpine (C02AA02)
- Rescinnamine (C02AA01)
- Cardiac therapy (C01)
- Other cardiac preparations (C01E)
- Other cardiac combination products (C01EX)
- Other cardiac preparations (C01EB)
- Mavacamten (C01EB24)
- Tiazotic acid (C01EB23)
- Meldonium (C01EB22)
- Regadenoson (C01EB21)
- Ranolazine (C01EB18)
- Ivabradine (C01EB17)
- Ibuprofen (C01EB16)
- Trimetazidine (C01EB15)
- Acadesine (C01EB13)
- Tiracizine (C01EB11)
- Adenosine (C01EB10)
- Ubidecarenone (C01EB09)
- Fructose 1,6-diphosphate (C01EB07)
- Fosfocreatine (C01EB06)
- Creatinolfosfate (C01EB05)
- Crataegus glycosides (C01EB04)
- Indometacin (C01EB03)
- Camphora (C01EB02)
- Prostaglandins (C01EA)
- Vasodilators used in cardiac diseases (C01D)
- Other vasodilators used in cardiac diseases (C01DX)
- Vericiguat (C01DX22)
- Benziodarone, combinations (C01DX54)
- Oxyfedrine, combinations (C01DX53)
- Prenylamine, combinations (C01DX52)
- Itramin tosilate, combinations (C01DX51)
- Serelaxin (C01DX21)
- Nesiritide (C01DX19)
- Linsidomine (C01DX18)
- Nicorandil (C01DX16)
- Cloridarol (C01DX15)
- Cinepazet (C01DX14)
- Efloxate (C01DX13)
- Molsidomine (C01DX12)
- Trapidil (C01DX11)
- Dilazep (C01DX10)
- Imolamine (C01DX09)
- Heptaminol (C01DX08)
- Etafenone (C01DX07)
- Hexobendine (C01DX06)
- Carbocromen (C01DX05)
- Benziodarone (C01DX04)
- Oxyfedrine (C01DX03)
- Prenylamine (C01DX02)
- Itramin tosilate (C01DX01)
- Quinolone vasodilators (C01DB)
- Organic nitrates (C01DA)
- Organic nitrates in combination with psycholeptics (C01DA70)
- Eritrityl tetranitrate, combinations (C01DA63)
- Trolnitrate, combinations (C01DA59)
- Isosorbide dinitrate, combinations (C01DA58)
- Propatylnitrate, combinations (C01DA57)
- Pentaerithrityl tetranitrate, combinations (C01DA55)
- Methylpropylpropanediol dinitrate, combinations (C01DA54)
- Glyceryl trinitrate, combinations (C01DA52)
- Tenitramine (C01DA38)
- Organic nitrates in combination (C01DA20)
- Isosorbide mononitrate (C01DA14)
- Eritrityl tetranitrate (C01DA13)
- Trolnitrate (C01DA09)
- Isosorbide dinitrate (C01DA08)
- Propatylnitrate (C01DA07)
- Pentaerithrityl tetranitrate (C01DA05)
- Methylpropylpropanediol dinitrate (C01DA04)
- Glyceryl trinitrate (C01DA02)
- Other vasodilators used in cardiac diseases (C01DX)
- Cardiac stimulants excl. cardiac glycosides (C01C)
- Other cardiac stimulants (C01CX)
- Phosphodiesterase inhibitors (C01CE)
- Adrenergic and dopaminergic agents (C01CA)
- Centhaquine (C01CA28)
- Etilefrine, combinations (C01CA51)
- Combinations (C01CA30)
- Droxidopa (C01CA27)
- Ephedrine (C01CA26)
- Amezinium metilsulfate (C01CA25)
- Epinephrine (C01CA24)
- Theodrenaline (C01CA23)
- Arbutamine (C01CA22)
- Cafedrine (C01CA21)
- Fenoldopam (C01CA19)
- Octopamine (C01CA18)
- Midodrine (C01CA17)
- Ibopamine (C01CA16)
- Gepefrine (C01CA15)
- Dopexamine (C01CA14)
- Prenalterol (C01CA13)
- Dimetofrine (C01CA12)
- Mephentermine (C01CA11)
- Methoxamine (C01CA10)
- Metaraminol (C01CA09)
- Oxedrine (C01CA08)
- Dobutamine (C01CA07)
- Phenylephrine (C01CA06)
- Norfenefrine (C01CA05)
- Dopamine (C01CA04)
- Norepinephrine (C01CA03)
- Isoprenaline (C01CA02)
- Etilefrine (C01CA01)
- Antiarrhythmics, class i and iii (C01B)
- Other antiarrhythmics, class i and iii (C01BG)
- Antiarrhythmics, class iii (C01BD)
- Antiarrhythmics, class ic (C01BC)
- Antiarrhythmics, class ib (C01BB)
- Antiarrhythmics, class ia (C01BA)
- Cardiac glycosides (C01A)
- Other cardiac glycosides (C01AX)
- Strophanthus glycosides (C01AC)
- Scilla glycosides (C01AB)
- Digitalis glycosides (C01AA)
- Other cardiac preparations (C01E)
- Lipid modifying agents (C10)
- Dermatologicals (D)
- Other dermatological preparations (D11)
- Other dermatological preparations (D11A)
- Other dermatologicals (D11AX)
- Oxymetazoline (D11AX27)
- Caffeine (D11AX26)
- Hydrogen peroxide (D11AX25)
- Deoxycholic acid (D11AX24)
- Aminobenzoate potassium (D11AX23)
- Collagen, combinations (D11AX57)
- Gamolenic acid, combinations (D11AX52)
- Ivermectin (D11AX22)
- Brimonidine (D11AX21)
- Diclofenac (D11AX18)
- Eflornithine (D11AX16)
- Monobenzone (D11AX13)
- Pyrithione zinc (D11AX12)
- Hydroquinone (D11AX11)
- Finasteride (D11AX10)
- Oxaceprol (D11AX09)
- Tiratricol (D11AX08)
- Mequinol (D11AX06)
- Magnesium sulfate (D11AX05)
- Lithium succinate (D11AX04)
- Calcium gluconate (D11AX03)
- Gamolenic acid (D11AX02)
- Minoxidil (D11AX01)
- Agents for dermatitis, excluding corticosteroids (D11AH)
- Wart and anti-corn preparations (D11AF)
- Androgens for topical use (D11AE)
- Medicated shampoos (D11AC)
- Antihidrotics (D11AA)
- Other dermatologicals (D11AX)
- Other dermatological preparations (D11A)
- Anti-acne preparations (D10)
- Anti-acne preparations for systemic use (D10B)
- Anti-acne preparations for topical use (D10A)
- Other anti-acne preparations for topical use (D10AX)
- Antiinfectives for treatment of acne (D10AF)
- Peroxides (D10AE)
- Retinoids for topical use in acne (D10AD)
- Preparations containing sulfur (D10AB)
- Corticosteroids, combinations for treatment of acne (D10AA)
- Medicated dressings (D09)
- Medicated dressings (D09A)
- Soft paraffin dressings (D09AX)
- Zinc bandages (D09AB)
- Medicated dressings with antiinfectives (D09AA)
- Iodoform (D09AA13)
- Chlorhexidine (D09AA12)
- Benzalkonium (D09AA11)
- Clioquinol (D09AA10)
- Povidone-iodine (D09AA09)
- Aluminium chlorohydrate (D09AA08)
- Cetylpyridinium (D09AA07)
- Triclosan (D09AA06)
- Benzododecinium (D09AA05)
- Phenylmercuric nitrate (D09AA04)
- Nitrofural (D09AA03)
- Fusidic acid (D09AA02)
- Framycetin (D09AA01)
- Medicated dressings (D09A)
- Antiseptics and disinfectants (D08)
- Antiseptics and disinfectants (D08A)
- Other antiseptics and disinfectants (D08AX)
- Silver compounds (D08AL)
- Mercurial products (D08AK)
- Quaternary ammonium compounds (D08AJ)
- Dodeclonium bromide, combinations (D08AJ59)
- Benzethonium chloride, combinations (D08AJ58)
- Octenidine, combinations (D08AJ57)
- Decamethoxine (D08AJ10)
- Benzethonium chloride (D08AJ08)
- Didecyldimethylammonium chloride (D08AJ06)
- Benzoxonium chloride (D08AJ05)
- Cetrimide (D08AJ04)
- Cetylpyridinium (D08AJ03)
- Cetrimonium (D08AJ02)
- Benzalkonium (D08AJ01)
- Quinoline derivatives (D08AH)
- Iodine products (D08AG)
- Nitrofuran derivatives (D08AF)
- Phenol and derivatives (D08AE)
- Boric acid products (D08AD)
- Biguanides and amidines (D08AC)
- Aluminium agents (D08AB)
- Acridine derivatives (D08AA)
- Antiseptics and disinfectants (D08A)
- Corticosteroids, dermatological preparations (D07)
- Corticosteroids, other combinations (D07X)
- Corticosteroids, combinations with antibiotics (D07C)
- Corticosteroids, very potent, combinations with antibiotics (D07CD)
- Corticosteroids, potent, combinations with antibiotics (D07CC)
- Corticosteroids, moderately potent, combinations with antibiotics (D07CB)
- Corticosteroids, weak, combinations with antibiotics (D07CA)
- Corticosteroids, combinations with antiseptics (D07B)
- Corticosteroids, plain (D07A)
- Corticosteroids, very potent (group iv) (D07AD)
- Corticosteroids, potent (group iii) (D07AC)
- Ulobetasol (D07AC21)
- Difluprednate (D07AC19)
- Prednicarbate (D07AC18)
- Fluticasone (D07AC17)
- Hydrocortisone aceponate (D07AC16)
- Beclometasone (D07AC15)
- Methylprednisolone aceponate (D07AC14)
- Mometasone (D07AC13)
- Halometasone (D07AC12)
- Amcinonide (D07AC11)
- Diflorasone (D07AC10)
- Budesonide (D07AC09)
- Fluocinonide (D07AC08)
- Fludroxycortide (D07AC07)
- Diflucortolone (D07AC06)
- Fluocortolone (D07AC05)
- Fluocinolone acetonide (D07AC04)
- Desoximetasone (D07AC03)
- Fluclorolone (D07AC02)
- Betamethasone (D07AC01)
- Corticosteroids, moderately potent (group ii) (D07AB)
- Combinations of corticosteroids (D07AB30)
- Clocortolone (D07AB21)
- Dexamethasone (D07AB19)
- Hydrocortisone buteprate (D07AB11)
- Alclometasone (D07AB10)
- Triamcinolone (D07AB09)
- Desonide (D07AB08)
- Fluprednidene (D07AB07)
- Fluorometholone (D07AB06)
- Fluperolone (D07AB05)
- Fluocortin (D07AB04)
- Flumetasone (D07AB03)
- Hydrocortisone butyrate (D07AB02)
- Clobetasone (D07AB01)
- Corticosteroids, weak (group i) (D07AA)
- Antibiotics and chemotherapeutics for dermatological use (D06)
- Antibiotics and chemotherapeutics, combinations (D06C)
- Chemotherapeutics for topical use (D06B)
- Other chemotherapeutics (D06BX)
- Antivirals (D06BB)
- Sulfonamides (D06BA)
- Antibiotics for topical use (D06A)
- Other antibiotics for topical use (D06AX)
- Tetracycline and derivatives (D06AA)
- Antipsoriatics (D05)
- Antipsoriatics for systemic use (D05B)
- Antipsoriatics for topical use (D05A)
- Other antipsoriatics for topical use (D05AX)
- Psoralens for topical use (D05AD)
- Antracen derivatives (D05AC)
- Tars (D05AA)
- Antipruritics, incl. antihistamines, anesthetics, etc. (D04)
- Antipruritics, incl. antihistamines, anesthetics, etc. (D04A)
- Other antipruritics (D04AX)
- Anesthetics for topical use (D04AB)
- Antihistamines for topical use (D04AA)
- Chlorphenoxamine (D04AA34)
- Diphenhydramine methylbromide (D04AA33)
- Diphenhydramine (D04AA32)
- Isothipendyl (D04AA22)
- Pheniramine (D04AA16)
- Bamipine (D04AA15)
- Clemastine (D04AA14)
- Dimetindene (D04AA13)
- Tolpropamine (D04AA12)
- Promethazine (D04AA10)
- Chloropyramine (D04AA09)
- Tripelennamine (D04AA04)
- Thenalidine (D04AA03)
- Mepyramine (D04AA02)
- Thonzylamine (D04AA01)
- Antipruritics, incl. antihistamines, anesthetics, etc. (D04A)
- Preparations for treatment of wounds and ulcers (D03)
- Enzymes (D03B)
- Cicatrizants (D03A)
- Other cicatrizants (D03AX)
- Beremagene geperpavec (D03AX16)
- Trafermin (D03AX15)
- Centella asiatica herba, incl. combinations (D03AX14)
- Betulae cortex (D03AX13)
- Trolamine (D03AX12)
- Sodium chlorite (D03AX11)
- Enoxolone (D03AX10)
- Crilanomer (D03AX09)
- Becaplermin (D03AX06)
- Hyaluronic acid (D03AX05)
- Calcium pantothenate (D03AX04)
- Dexpanthenol (D03AX03)
- Dextranomer (D03AX02)
- Cadexomer iodine (D03AX01)
- Cod-liver oil ointments (D03AA)
- Other cicatrizants (D03AX)
- Emollients and protectives (D02)
- Antifungals for dermatological use (D01)
- Antifungals for systemic use (D01B)
- Antifungals for topical use (D01A)
- Other antifungals for topical use (D01AE)
- Liranaftate (D01AE25)
- Tavaborole (D01AE24)
- Undecylenic acid, combinations (D01AE54)
- Butenafine (D01AE23)
- Naftifine (D01AE22)
- Flucytosine (D01AE21)
- Combinations (D01AE20)
- Tolciclate (D01AE19)
- Tolnaftate (D01AE18)
- Dimazole (D01AE17)
- Amorolfine (D01AE16)
- Terbinafine (D01AE15)
- Ciclopirox (D01AE14)
- Selenium sulfide (D01AE13)
- Salicylic acid (D01AE12)
- Haloprogin (D01AE11)
- Ethyl hydroxybenzoate (D01AE10)
- Sulbentine (D01AE09)
- Ticlatone (D01AE08)
- Chlorphenesin (D01AE07)
- 2-(4-chlorphenoxy)-ethanol (D01AE06)
- Polynoxylin (D01AE05)
- Undecylenic acid (D01AE04)
- Tribromometacresol (D01AE03)
- Methylrosaniline (D01AE02)
- Bromochlorosalicylanilide (D01AE01)
- Imidazole and triazole derivatives (D01AC)
- Lanoconazole (D01AC22)
- Neticonazole (D01AC21)
- Bifonazole, combinations (D01AC60)
- Miconazole, combinations (D01AC52)
- Imidazoles/triazoles in combination with corticosteroids (D01AC20)
- Efinaconazole (D01AC19)
- Luliconazole (D01AC18)
- Eberconazole (D01AC17)
- Flutrimazole (D01AC16)
- Fluconazole (D01AC15)
- Sertaconazole (D01AC14)
- Omoconazole (D01AC13)
- Fenticonazole (D01AC12)
- Oxiconazole (D01AC11)
- Bifonazole (D01AC10)
- Sulconazole (D01AC09)
- Ketoconazole (D01AC08)
- Tioconazole (D01AC07)
- Tiabendazole (D01AC06)
- Isoconazole (D01AC05)
- Chlormidazole (D01AC04)
- Econazole (D01AC03)
- Miconazole (D01AC02)
- Clotrimazole (D01AC01)
- Antibiotics (D01AA)
- Other antifungals for topical use (D01AE)
- Other dermatological preparations (D11)
- Genito urinary system and sex hormones (G)
- Urologicals (G04)
- Drugs used in benign prostatic hypertrophy (G04C)
- Other drugs used in benign prostatic hypertrophy (G04CX)
- Testosterone-5-alpha reductase inhibitors (G04CB)
- Alpha-adrenoreceptor antagonists (G04CA)
- Urologicals (G04B)
- Other urologicals (G04BX)
- Drugs used in erectile dysfunction (G04BE)
- Drugs for urinary frequency and incontinence (G04BD)
- Vibegron (G04BD15)
- Imidafenacin (G04BD14)
- Desfesoterodine (G04BD13)
- Mirabegron (G04BD12)
- Fesoterodine (G04BD11)
- Darifenacin (G04BD10)
- Trospium (G04BD09)
- Solifenacin (G04BD08)
- Tolterodine (G04BD07)
- Propiverine (G04BD06)
- Terodiline (G04BD05)
- Oxybutynin (G04BD04)
- Meladrazine (G04BD03)
- Flavoxate (G04BD02)
- Emepronium (G04BD01)
- Urinary concrement solvents (G04BC)
- Acidifiers (G04BA)
- Drugs used in benign prostatic hypertrophy (G04C)
- Sex hormones and modulators of the genital system (G03)
- Other sex hormones and modulators of the genital system (G03X)
- Antiandrogens (G03H)
- Gonadotropins and other ovulation stimulants (G03G)
- Ovulation stimulants, synthetic (G03GB)
- Gonadotropins (G03GA)
- Follitropin delta (G03GA10)
- Combinations (G03GA30)
- Corifollitropin alfa (G03GA09)
- Choriogonadotropin alfa (G03GA08)
- Lutropin alfa (G03GA07)
- Follitropin beta (G03GA06)
- Follitropin alfa (G03GA05)
- Urofollitropin (G03GA04)
- Serum gonadotrophin (G03GA03)
- Human menopausal gonadotrophin (G03GA02)
- Chorionic gonadotrophin (G03GA01)
- Progestogens and estrogens in combination (G03F)
- Progestogens and estrogens, sequential preparations (G03FB)
- Nomegestrol and estrogen (G03FB12)
- Trimegestone and estrogen (G03FB11)
- Desogestrel and estrogen (G03FB10)
- Levonorgestrel and estrogen (G03FB09)
- Dydrogesterone and estrogen (G03FB08)
- Medrogestone and estrogen (G03FB07)
- Medroxyprogesterone and estrogen (G03FB06)
- Norethisterone and estrogen (G03FB05)
- Megestrol and estrogen (G03FB04)
- Chlormadinone and estrogen (G03FB03)
- Lynestrenol and estrogen (G03FB02)
- Norgestrel and estrogen (G03FB01)
- Progestogens and estrogens, fixed combinations (G03FA)
- Drospirenone and estrogen (G03FA17)
- Trimegestone and estrogen (G03FA16)
- Dienogest and estrogen (G03FA15)
- Dydrogesterone and estrogen (G03FA14)
- Norgestimate and estrogen (G03FA13)
- Medroxyprogesterone and estrogen (G03FA12)
- Levonorgestrel and estrogen (G03FA11)
- Norgestrel and estrogen (G03FA10)
- Noretynodrel and estrogen (G03FA09)
- Megestrol and estrogen (G03FA08)
- Lynestrenol and estrogen (G03FA07)
- Etynodiol and estrogen (G03FA06)
- Methylnortestosterone and estrogen (G03FA05)
- Progesterone and estrogen (G03FA04)
- Ethisterone and estrogen (G03FA03)
- Hydroxyprogesterone and estrogen (G03FA02)
- Norethisterone and estrogen (G03FA01)
- Progestogens and estrogens, sequential preparations (G03FB)
- Androgens and female sex hormones in combination (G03E)
- Progestogens (G03D)
- Estrogens (G03C)
- Androgens (G03B)
- Hormonal contraceptives for systemic use (G03A)
- Emergency contraceptives (G03AD)
- Progestogens (G03AC)
- Progestogens and estrogens, sequential preparations (G03AB)
- Norgestimate and ethinylestradiol (G03AB09)
- Dienogest and estradiol (G03AB08)
- Chlormadinone and ethinylestradiol (G03AB07)
- Gestodene and ethinylestradiol (G03AB06)
- Desogestrel and ethinylestradiol (G03AB05)
- Norethisterone and ethinylestradiol (G03AB04)
- Levonorgestrel and ethinylestradiol (G03AB03)
- Lynestrenol and ethinylestradiol (G03AB02)
- Megestrol and ethinylestradiol (G03AB01)
- Progestogens and estrogens, fixed combinations (G03AA)
- Drospirenone and estetrol (G03AA18)
- Medroxyprogesterone and estradiol (G03AA17)
- Dienogest and ethinylestradiol (G03AA16)
- Chlormadinone and ethinylestradiol (G03AA15)
- Nomegestrol and estradiol (G03AA14)
- Norelgestromin and ethinylestradiol (G03AA13)
- Drospirenone and ethinylestradiol (G03AA12)
- Norgestimate and ethinylestradiol (G03AA11)
- Gestodene and ethinylestradiol (G03AA10)
- Desogestrel and ethinylestradiol (G03AA09)
- Medroxyprogesterone and ethinylestradiol (G03AA08)
- Levonorgestrel and ethinylestradiol (G03AA07)
- Norgestrel and ethinylestradiol (G03AA06)
- Norethisterone and ethinylestradiol (G03AA05)
- Megestrol and ethinylestradiol (G03AA04)
- Lynestrenol and ethinylestradiol (G03AA03)
- Quingestanol and ethinylestradiol (G03AA02)
- Etynodiol and ethinylestradiol (G03AA01)
- Other gynecologicals (G02)
- Gynecological antiinfectives and antiseptics (G01)
- Antiinfectives/antiseptics in combination with corticosteroids (G01B)
- Antiinfectives and antiseptics, excl. combinations with corticosteroids (G01A)
- Other antiinfectives and antiseptics (G01AX)
- Dapivirine (G01AX17)
- Octenidine, combinations (G01AX66)
- Hexetidine (G01AX16)
- Copper usnate (G01AX15)
- Lactobacillus (G01AX14)
- Protiofate (G01AX13)
- Ciclopirox (G01AX12)
- Povidone-iodine (G01AX11)
- Methylrosaniline (G01AX09)
- Furazolidone (G01AX06)
- Nifuratel (G01AX05)
- Policresulen (G01AX03)
- Inosine (G01AX02)
- Clodantoin (G01AX01)
- Triazole derivatives (G01AG)
- Imidazole derivatives (G01AF)
- Tinidazole (G01AF21)
- Econazole, combinations (G01AF55)
- Combinations of imidazole derivatives (G01AF20)
- Sertaconazole (G01AF19)
- Flutrimazole (G01AF18)
- Oxiconazole (G01AF17)
- Omoconazole (G01AF16)
- Butoconazole (G01AF15)
- Propenidazole (G01AF14)
- Azanidazole (G01AF13)
- Fenticonazole (G01AF12)
- Ketoconazole (G01AF11)
- Tioconazole (G01AF08)
- Isoconazole (G01AF07)
- Ornidazole (G01AF06)
- Econazole (G01AF05)
- Miconazole (G01AF04)
- Clotrimazole (G01AF02)
- Metronidazole (G01AF01)
- Sulfonamides (G01AE)
- Combinations of sulfonamides (G01AE10)
- Brinzolamide
- Sulfamethazine
- Meticrane
- Diazoxide
- Sulfathiazole
- Mitapivat
- Sulfadoxine
- Acetyl sulfisoxazole
- Bosentan
- Chlorpropamide
- Benzthiazide
- Simeprevir
- Hydroflumethiazide
- Mafenide
- Gefapixant
- Tamsulosin
- Sulfametopyrazine
- Furosemide
- Sulfamethoxazole
- Acetohexamide
- Chlorothiazide
- Glymidine
- Sulfadimethoxine
- Dorzolamide
- Sumatriptan
- Udenafil
- Probenecid
- Chlorthalidone
- Quinethazone
- Acetazolamide
- Phthalylsulfathiazole
- Sulthiame
- Silver sulfadiazine
- Bumetanide
- Cyclothiazide
- Rosuvastatin
- Sulfameter
- Sulfacytine
- Darunavir
- Sulfanilamide
- Sulfisoxazole
- Sildenafil
- Diclofenamide
- Bendroflumethiazide
- Sulfamethizole
- Valdecoxib
- Tolazamide
- Sulfadiazine
- Gliclazide
- Sulfaphenazole
- Piretanide
- Hydrochlorothiazide
- Tolbutamide
- Torasemide
- Metolazone
- Zonisamide
- Polythiazide
- Methazolamide
- Fedratinib
- Indapamide
- Vemurafenib
- Sulfacetamide
- Sulfasalazine
- Omidenepag isopropyl
- Sulfamerazine
- Trichlormethiazide
- Sulfapyridine
- Celecoxib
- Cyclopenthiazide
- Sulfatolamide (G01AE01)
- Combinations of sulfonamides (G01AE10)
- Organic acids (G01AD)
- Quinoline derivatives (G01AC)
- Arsenic compounds (G01AB)
- Antibiotics (G01AA)
- Other antiinfectives and antiseptics (G01AX)
- Urologicals (G04)
- Systemic hormonal preparations, excl. sex hormones and insulins (H)
- Calcium homeostasis (H05)
- Pancreatic hormones (H04)
- Thyroid therapy (H03)
- Corticosteroids for systemic use (H02)
- Antiadrenal preparations (H02C)
- Corticosteroids for systemic use, combinations (H02B)
- Corticosteroids for systemic use, plain (H02A)
- Glucocorticoids (H02AB)
- Vamorolone (H02AB18)
- Cortivazol (H02AB17)
- Meprednisone (H02AB15)
- Cloprednol (H02AB14)
- Deflazacort (H02AB13)
- Rimexolone (H02AB12)
- Prednylidene (H02AB11)
- Cortisone (H02AB10)
- Hydrocortisone (H02AB09)
- Triamcinolone (H02AB08)
- Prednisone (H02AB07)
- Prednisolone (H02AB06)
- Paramethasone (H02AB05)
- Methylprednisolone (H02AB04)
- Fluocortolone (H02AB03)
- Dexamethasone (H02AB02)
- Betamethasone (H02AB01)
- Mineralocorticoids (H02AA)
- Glucocorticoids (H02AB)
- Pituitary and hypothalamic hormones and analogues (H01)
- Hypothalamic hormones (H01C)
- Posterior pituitary lobe hormones (H01B)
- Anterior pituitary lobe hormones and analogues (H01A)
- Other anterior pituitary lobe hormones and analogues (H01AX)
- Somatropin and somatropin agonists (H01AC)
- Thyrotropin (H01AB)
- Acth (H01AA)
- Antiinfectives for systemic use (J)
- Vaccines (J07)
- Other vaccines (J07X)
- Bacterial and viral vaccines, combined (J07C)
- Bacterial and viral vaccines, combined (J07CA)
- Diphtheria-haemophilus influenzae b-pertussis-tetanus-hepatitis b-meningococcus a + c (J07CA13)
- Diphtheria-pertussis-poliomyelitis-tetanus-hepatitis b (J07CA12)
- Diphtheria-haemophilus influenzae b-pertussis-tetanus-hepatitis b (J07CA11)
- Typhoid-hepatitis a (J07CA10)
- Diphtheria-haemophilus influenzae b-pertussis-poliomyelitis-tetanus-hepatitis b (J07CA09)
- Haemophilus influenzae b and hepatitis b (J07CA08)
- Diphtheria-hepatitis b-tetanus (J07CA07)
- Diphtheria-haemophilus influenzae b-pertussis-poliomyelitis-tetanus (J07CA06)
- Diphtheria-hepatitis b-pertussis-tetanus (J07CA05)
- Haemophilus influenzae b and poliomyelitis (J07CA04)
- Diphtheria-rubella-tetanus (J07CA03)
- Diphtheria-pertussis-poliomyelitis-tetanus (J07CA02)
- Diphtheria-poliomyelitis-tetanus (J07CA01)
- Bacterial and viral vaccines, combined (J07CA)
- Viral vaccines (J07B)
- Covid-19 vaccines (J07BN)
- Other viral vaccines (J07BX)
- Papillomavirus vaccines (J07BM)
- Yellow fever vaccines (J07BL)
- Varicella zoster vaccines (J07BK)
- Rubella vaccines (J07BJ)
- Rota virus diarrhea vaccines (J07BH)
- Rabies vaccines (J07BG)
- Poliomyelitis vaccines (J07BF)
- Mumps vaccines (J07BE)
- Measles vaccines (J07BD)
- Measles, combinations with mumps, rubella and varicella, live attenuated (J07BD54)
- Measles, combinations with rubella, live attenuated (J07BD53)
- Measles, combinations with mumps and rubella, live attenuated (J07BD52)
- Measles, combinations with mumps, live attenuated (J07BD51)
- Measles, live attenuated (J07BD01)
- Hepatitis vaccines (J07BC)
- Influenza vaccines (J07BB)
- Encephalitis vaccines (J07BA)
- Bacterial vaccines (J07A)
- Other bacterial vaccines (J07AX)
- Typhus (exanthematicus) vaccines (J07AR)
- Typhoid vaccines (J07AP)
- Tuberculosis vaccines (J07AN)
- Tetanus vaccines (J07AM)
- Pneumococcal vaccines (J07AL)
- Plague vaccines (J07AK)
- Pertussis vaccines (J07AJ)
- Meningococcal vaccines (J07AH)
- Meningococcus a, purified polysaccharides antigen conjugated (J07AH10)
- Meningococcus b, multicomponent vaccine (J07AH09)
- Meningococcus a,c,y,w-135, tetravalent purified polysaccharides antigen conjugated (J07AH08)
- Meningococcus c, purified polysaccharides antigen conjugated (J07AH07)
- Meningococcus b, outer membrane vesicle vaccine (J07AH06)
- Other meningococcal polyvalent purified polysaccharides antigen (J07AH05)
- Meningococcus a,c,y,w-135, tetravalent purified polysaccharides antigen (J07AH04)
- Meningococcus a,c, bivalent purified polysaccharides antigen (J07AH03)
- Other meningococcal monovalent purified polysaccharides antigen (J07AH02)
- Meningococcus a, purified polysaccharides antigen (J07AH01)
- Haemophilus influenzae b vaccines (J07AG)
- Haemophilus influenza b, combinations with meningococcus c,y, conjugated (J07AG54)
- Haemophilus influenzae b, combinations with meningococcus c, conjugated (J07AG53)
- Haemophilus influenzae b, combinations with pertussis and toxoids (J07AG52)
- Haemophilus influenzae b, combinations with toxoids (J07AG51)
- Haemophilus influenzae b, purified antigen conjugated (J07AG01)
- Diphtheria vaccines (J07AF)
- Cholera vaccines (J07AE)
- Brucellosis vaccines (J07AD)
- Anthrax vaccines (J07AC)
- Immune sera and immunoglobulins (J06)
- Immunoglobulins (J06B)
- Antiviral monoclonal antibodies (J06BD)
- Antibacterial monoclonal antibodies (J06BC)
- Specific immunoglobulins (J06BB)
- Combinations (J06BB30)
- Anthrax immunoglobulin (J06BB19)
- Mumps immunoglobulin (J06BB15)
- Measles immunoglobulin (J06BB14)
- Pertussis immunoglobulin (J06BB13)
- Encephalitis, tick borne immunoglobulin (J06BB12)
- Hepatitis a immunoglobulin (J06BB11)
- Diphtheria immunoglobulin (J06BB10)
- Cytomegalovirus immunoglobulin (J06BB09)
- Staphylococcus immunoglobulin (J06BB08)
- Vaccinia immunoglobulin (J06BB07)
- Rubella immunoglobulin (J06BB06)
- Rabies immunoglobulin (J06BB05)
- Hepatitis b immunoglobulin (J06BB04)
- Varicella/zoster immunoglobulin (J06BB03)
- Tetanus immunoglobulin (J06BB02)
- Anti-d (rh) immunoglobulin (J06BB01)
- Immunoglobulins, normal human (J06BA)
- Immune sera (J06A)
- Immunoglobulins (J06B)
- Antivirals for systemic use (J05)
- Direct acting antivirals (J05A)
- Integrase inhibitors (J05AJ)
- Antivirals for treatment of hcv infections (J05AP)
- Ravidasvir (J05AP13)
- Coblopasvir (J05AP12)
- Daclatasvir, asunaprevir and beclabuvir (J05AP58)
- Grazoprevir (J05AP11)
- Elbasvir (J05AP10)
- Glecaprevir and pibrentasvir (J05AP57)
- Sofosbuvir, velpatasvir and voxilaprevir (J05AP56)
- Sofosbuvir and velpatasvir (J05AP55)
- Elbasvir and grazoprevir (J05AP54)
- Ombitasvir, paritaprevir and ritonavir (J05AP53)
- Dasabuvir, ombitasvir, paritaprevir and ritonavir (J05AP52)
- Sofosbuvir and ledipasvir (J05AP51)
- Dasabuvir (J05AP09)
- Sofosbuvir (J05AP08)
- Daclatasvir (J05AP07)
- Asunaprevir (J05AP06)
- Simeprevir (J05AP05)
- Faldaprevir (J05AP04)
- Boceprevir (J05AP03)
- Telaprevir (J05AP02)
- Ribavirin (J05AP01)
- Other antivirals (J05AX)
- Lenacapavir (J05AX31)
- Fostemsavir (J05AX29)
- Bulevirtide (J05AX28)
- Favipiravir (J05AX27)
- Amenamevir (J05AX26)
- Baloxavir marboxil (J05AX25)
- Tecovirimat (J05AX24)
- Ibalizumab (J05AX23)
- Pentanedioic acid imidazolyl ethanamide (J05AX21)
- Tilorone (J05AX19)
- Letermovir (J05AX18)
- Enisamium iodide (J05AX17)
- Umifenovir (J05AX13)
- Maribavir (J05AX10)
- Maraviroc (J05AX09)
- Enfuvirtide (J05AX07)
- Pleconaril (J05AX06)
- Inosine pranobex (J05AX05)
- Lysozyme (J05AX02)
- Moroxydine (J05AX01)
- Antivirals for treatment of hiv infections, combinations (J05AR)
- Stavudine and lamivudine (J05AR28)
- Lamivudine, tenofovir disoproxil and dolutegravir (J05AR27)
- Darunavir and ritonavir (J05AR26)
- Lamivudine and dolutegravir (J05AR25)
- Lamivudine, tenofovir disoproxil and doravirine (J05AR24)
- Atazanavir and ritonavir (J05AR23)
- Emtricitabine, tenofovir alafenamide, darunavir and cobicistat (J05AR22)
- Dolutegravir and rilpivirine (J05AR21)
- Emtricitabine, tenofovir alafenamide and bictegravir (J05AR20)
- Emtricitabine, tenofovir alafenamide and rilpivirine (J05AR19)
- Emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat (J05AR18)
- Emtricitabine and tenofovir alafenamide (J05AR17)
- Lamivudine and raltegravir (J05AR16)
- Atazanavir and cobicistat (J05AR15)
- Darunavir and cobicistat (J05AR14)
- Lamivudine, abacavir and dolutegravir (J05AR13)
- Lamivudine and tenofovir disoproxil (J05AR12)
- Lamivudine, tenofovir disoproxil and efavirenz (J05AR11)
- Lopinavir and ritonavir (J05AR10)
- Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat (J05AR09)
- Emtricitabine, tenofovir disoproxil and rilpivirine (J05AR08)
- Stavudine, lamivudine and nevirapine (J05AR07)
- Emtricitabine, tenofovir disoproxil and efavirenz (J05AR06)
- Zidovudine, lamivudine and nevirapine (J05AR05)
- Zidovudine, lamivudine and abacavir (J05AR04)
- Tenofovir disoproxil and emtricitabine (J05AR03)
- Lamivudine and abacavir (J05AR02)
- Zidovudine and lamivudine (J05AR01)
- Neuraminidase inhibitors (J05AH)
- Non-nucleoside reverse transcriptase inhibitors (J05AG)
- Nucleoside and nucleotide reverse transcriptase inhibitors (J05AF)
- Protease inhibitors (J05AE)
- Phosphonic acid derivatives (J05AD)
- Cyclic amines (J05AC)
- Nucleosides and nucleotides excl. reverse transcriptase inhibitors (J05AB)
- Thiosemicarbazones (J05AA)
- Direct acting antivirals (J05A)
- Antimycobacterials (J04)
- Drugs for treatment of lepra (J04B)
- Drugs for treatment of tuberculosis (J04A)
- Combinations of drugs for treatment of tuberculosis (J04AM)
- Isoniazid, sulfamethoxazole, trimethoprim and pyridoxine (J04AM08)
- Rifampicin, ethambutol and isoniazid (J04AM07)
- Rifampicin, pyrazinamide, ethambutol and isoniazid (J04AM06)
- Rifampicin, pyrazinamide and isoniazid (J04AM05)
- Thioacetazone and isoniazid (J04AM04)
- Ethambutol and isoniazid (J04AM03)
- Rifampicin and isoniazid (J04AM02)
- Streptomycin and isoniazid (J04AM01)
- Other drugs for treatment of tuberculosis (J04AK)
- Thiocarbamide derivatives (J04AD)
- Hydrazides (J04AC)
- Antibiotics (J04AB)
- Aminosalicylic acid and derivatives (J04AA)
- Combinations of drugs for treatment of tuberculosis (J04AM)
- Antimycotics for systemic use (J02)
- Antibacterials for systemic use (J01)
- Other antibacterials (J01X)
- Other antibacterials (J01XX)
- Nitrofuran derivatives (J01XE)
- Imidazole derivatives (J01XD)
- Steroid antibacterials (J01XC)
- Polymyxins (J01XB)
- Glycopeptide antibacterials (J01XA)
- Combinations of antibacterials (J01R)
- Combinations of antibacterials (J01RA)
- Cefixime and azithromycin (J01RA16)
- Cefixime and ornidazole (J01RA15)
- Norfloxacin and metronidazole (J01RA14)
- Norfloxacin and tinidazole (J01RA13)
- Ciprofloxacin and ornidazole (J01RA12)
- Ciprofloxacin and tinidazole (J01RA11)
- Ciprofloxacin and metronidazole (J01RA10)
- Ofloxacin and ornidazole (J01RA09)
- Tetracycline and oleandomycin (J01RA08)
- Azithromycin, fluconazole and secnidazole (J01RA07)
- Cefepime and amikacin (J01RA06)
- Levofloxacin and ornidazole (J01RA05)
- Spiramycin and metronidazole (J01RA04)
- Cefuroxime and metronidazole (J01RA03)
- Sulfonamides, combinations with other antibacterials (excl. trimethoprim) (J01RA02)
- Penicillins, combinations with other antibacterials (J01RA01)
- Combinations of antibacterials (J01RA)
- Quinolone antibacterials (J01M)
- Other quinolones (J01MB)
- Fluoroquinolones (J01MA)
- Lascufloxacin (J01MA25)
- Levonadifloxacin (J01MA24)
- Delafloxacin (J01MA23)
- Tosufloxacin (J01MA22)
- Sitafloxacin (J01MA21)
- Garenoxacin (J01MA19)
- Pazufloxacin (J01MA18)
- Prulifloxacin (J01MA17)
- Gatifloxacin (J01MA16)
- Gemifloxacin (J01MA15)
- Moxifloxacin (J01MA14)
- Trovafloxacin (J01MA13)
- Levofloxacin (J01MA12)
- Grepafloxacin (J01MA11)
- Rufloxacin (J01MA10)
- Sparfloxacin (J01MA09)
- Fleroxacin (J01MA08)
- Lomefloxacin (J01MA07)
- Norfloxacin (J01MA06)
- Temafloxacin (J01MA05)
- Enoxacin (J01MA04)
- Pefloxacin (J01MA03)
- Ciprofloxacin (J01MA02)
- Ofloxacin (J01MA01)
- Aminoglycoside antibacterials (J01G)
- Other aminoglycosides (J01GB)
- Streptomycins (J01GA)
- Macrolides, lincosamides and streptogramins (J01F)
- Streptogramins (J01FG)
- Lincosamides (J01FF)
- Macrolides (J01FA)
- Solithromycin (J01FA16)
- Telithromycin (J01FA15)
- Flurithromycin (J01FA14)
- Dirithromycin (J01FA13)
- Rokitamycin (J01FA12)
- Miocamycin (J01FA11)
- Azithromycin (J01FA10)
- Clarithromycin (J01FA09)
- Troleandomycin (J01FA08)
- Josamycin (J01FA07)
- Roxithromycin (J01FA06)
- Oleandomycin (J01FA05)
- Midecamycin (J01FA03)
- Spiramycin (J01FA02)
- Erythromycin (J01FA01)
- Sulfonamides and trimethoprim (J01E)
- Combinations of sulfonamides and trimethoprim, incl. derivatives (J01EE)
- Long-acting sulfonamides (J01ED)
- Intermediate-acting sulfonamides (J01EC)
- Short-acting sulfonamides (J01EB)
- Trimethoprim and derivatives (J01EA)
- Other beta-lactam antibacterials (J01D)
- Other cephalosporins and penems (J01DI)
- Carbapenems (J01DH)
- Monobactams (J01DF)
- Fourth-generation cephalosporins (J01DE)
- Third-generation cephalosporins (J01DD)
- Cefixime and beta-lactamase inhibitor (J01DD58)
- Cefpodoxime and beta-lactamase inhibitor (J01DD64)
- Ceftriaxone and beta-lactamase inhibitor (J01DD63)
- Cefteram (J01DD18)
- Cefoperazone and beta-lactamase inhibitor (J01DD62)
- Ceftriaxone, combinations (J01DD54)
- Ceftazidime and beta-lactamase inhibitor (J01DD52)
- Cefotaxime and beta-lactamase inhibitor (J01DD51)
- Cefcapene (J01DD17)
- Cefditoren (J01DD16)
- Cefdinir (J01DD15)
- Ceftibuten (J01DD14)
- Cefpodoxime (J01DD13)
- Cefoperazone (J01DD12)
- Cefpiramide (J01DD11)
- Cefetamet (J01DD10)
- Cefodizime (J01DD09)
- Cefixime (J01DD08)
- Ceftizoxime (J01DD07)
- Latamoxef (J01DD06)
- Cefmenoxime (J01DD05)
- Ceftriaxone (J01DD04)
- Cefsulodin (J01DD03)
- Ceftazidime (J01DD02)
- Cefotaxime (J01DD01)
- Second-generation cephalosporins (J01DC)
- Cefuroxime and beta-lactamase inhibitor (J01DC52)
- Flomoxef (J01DC14)
- Cefbuperazone (J01DC13)
- Cefminox (J01DC12)
- Ceforanide (J01DC11)
- Cefprozil (J01DC10)
- Cefmetazole (J01DC09)
- Loracarbef (J01DC08)
- Cefotiam (J01DC07)
- Cefonicid (J01DC06)
- Cefotetan (J01DC05)
- Cefaclor (J01DC04)
- Cefamandole (J01DC03)
- Cefuroxime (J01DC02)
- Cefoxitin (J01DC01)
- First-generation cephalosporins (J01DB)
- Beta-lactam antibacterials, penicillins (J01C)
- Combinations of penicillins, incl. beta-lactamase inhibitors (J01CR)
- Combinations of penicillins (J01CR50)
- Pivmecillinam
- Meticillin
- Benzylpenicilloyl polylysine
- Sultamicillin
- Carindacillin
- Bacampicillin
- Nafcillin
- Ticarcillin
- Dicloxacillin
- Benzylpenicillin
- Piperacillin
- Oxacillin
- Ampicillin
- Carbenicillin
- Pivampicillin
- Flucloxacillin
- Azlocillin
- Cyclacillin
- Mezlocillin
- Amoxicillin
- Procaine benzylpenicillin
- Cloxacillin
- Pheneticillin
- Phenoxymethylpenicillin
- Hetacillin
- Temocillin
- Piperacillin and beta-lactamase inhibitor (J01CR05)
- Sultamicillin (J01CR04)
- Ticarcillin and beta-lactamase inhibitor (J01CR03)
- Amoxicillin and beta-lactamase inhibitor (J01CR02)
- Ampicillin and beta-lactamase inhibitor (J01CR01)
- Combinations of penicillins (J01CR50)
- Beta-lactamase inhibitors (J01CG)
- Beta-lactamase resistant penicillins (J01CF)
- Beta-lactamase sensitive penicillins (J01CE)
- Combinations (J01CE30)
- Benzathine phenoxymethylpenicillin (J01CE10)
- Procaine benzylpenicillin (J01CE09)
- Benzathine benzylpenicillin (J01CE08)
- Clometocillin (J01CE07)
- Penamecillin (J01CE06)
- Pheneticillin (J01CE05)
- Azidocillin (J01CE04)
- Propicillin (J01CE03)
- Phenoxymethylpenicillin (J01CE02)
- Benzylpenicillin (J01CE01)
- Penicillins with extended spectrum (J01CA)
- Ampicillin, combinations (J01CA51)
- Combinations (J01CA20)
- Aspoxicillin (J01CA19)
- Hetacillin (J01CA18)
- Temocillin (J01CA17)
- Sulbenicillin (J01CA16)
- Talampicillin (J01CA15)
- Metampicillin (J01CA14)
- Ticarcillin (J01CA13)
- Piperacillin (J01CA12)
- Mecillinam (J01CA11)
- Mezlocillin (J01CA10)
- Azlocillin (J01CA09)
- Pivmecillinam (J01CA08)
- Epicillin (J01CA07)
- Bacampicillin (J01CA06)
- Carindacillin (J01CA05)
- Amoxicillin (J01CA04)
- Carbenicillin (J01CA03)
- Pivampicillin (J01CA02)
- Ampicillin (J01CA01)
- Combinations of penicillins, incl. beta-lactamase inhibitors (J01CR)
- Amphenicols (J01B)
- Tetracyclines (J01A)
- Tetracyclines (J01AA)
- Omadacycline (J01AA15)
- Sarecycline (J01AA14)
- Eravacycline (J01AA13)
- Oxytetracycline, combinations (J01AA56)
- Combinations of tetracyclines (J01AA20)
- Tigecycline (J01AA12)
- Clomocycline (J01AA11)
- Penimepicycline (J01AA10)
- Rolitetracycline (J01AA09)
- Minocycline (J01AA08)
- Tetracycline (J01AA07)
- Oxytetracycline (J01AA06)
- Metacycline (J01AA05)
- Lymecycline (J01AA04)
- Chlortetracycline (J01AA03)
- Doxycycline (J01AA02)
- Demeclocycline (J01AA01)
- Tetracyclines (J01AA)
- Other antibacterials (J01X)
- Vaccines (J07)
- Antineoplastic and immunomodulating agents (L)
- Immunosuppressants (L04)
- Immunosuppressants (L04A)
- Dihydroorotate dehydrogenase (dhodh) inhibitors (L04AK)
- Complement inhibitors (L04AJ)
- Mammalian target of rapamycin (mtor) kinase inhibitors (L04AH)
- Monoclonal antibodies (L04AG)
- Rozanolixizumab (L04AG16)
- Divozilimab (L04AG15)
- Ublituximab (L04AG14)
- Teprotumumab (L04AG13)
- Ofatumumab (L04AG12)
- Anifrolumab (L04AG11)
- Inebilizumab (L04AG10)
- Emapalumab (L04AG09)
- Ocrelizumab (L04AG08)
- Begelomab (L04AG07)
- Alemtuzumab (L04AG06)
- Vedolizumab (L04AG05)
- Belimumab (L04AG04)
- Natalizumab (L04AG03)
- Efalizumab (L04AG02)
- Muromonab-cd3 (L04AG01)
- Janus-associated kinase (jak) inhibitors (L04AF)
- Sphingosine-1-phosphate (s1p) receptor modulators (L04AE)
- Other immunosuppressants (L04AX)
- Calcineurin inhibitors (L04AD)
- Interleukin inhibitors (L04AC)
- Levilimab (L04AC25)
- Mirikizumab (L04AC24)
- Olokizumab (L04AC23)
- Spesolimab (L04AC22)
- Bimekizumab (L04AC21)
- Netakimab (L04AC20)
- Satralizumab (L04AC19)
- Risankizumab (L04AC18)
- Tildrakizumab (L04AC17)
- Guselkumab (L04AC16)
- Sirukumab (L04AC15)
- Sarilumab (L04AC14)
- Ixekizumab (L04AC13)
- Brodalumab (L04AC12)
- Siltuximab (L04AC11)
- Secukinumab (L04AC10)
- Briakinumab (L04AC09)
- Canakinumab (L04AC08)
- Tocilizumab (L04AC07)
- Ustekinumab (L04AC05)
- Rilonacept (L04AC04)
- Anakinra (L04AC03)
- Basiliximab (L04AC02)
- Daclizumab (L04AC01)
- Tumor necrosis factor alpha (tnf-alpha) inhibitors (L04AB)
- Selective immunosuppressants (L04AA)
- Efgartigimod alfa (L04AA58)
- Belumosudil (L04AA48)
- Imlifidase (L04AA41)
- Cladribine (L04AA40)
- Apremilast (L04AA32)
- Belatacept (L04AA28)
- Abatacept (L04AA24)
- Abetimus (L04AA22)
- Gusperimus (L04AA19)
- Alefacept (L04AA15)
- Mycophenolic acid (L04AA06)
- Antithymocyte immunoglobulin (rabbit) (L04AA04)
- Antilymphocyte immunoglobulin (horse) (L04AA03)
- Immunosuppressants (L04A)
- Immunostimulants (L03)
- Immunostimulants (L03A)
- Other immunostimulants (L03AX)
- Leniolisib (L03AX22)
- Elapegademase (L03AX21)
- Dasiprotimut-t (L03AX19)
- Cridanimod (L03AX18)
- Sipuleucel-t (L03AX17)
- Plerixafor (L03AX16)
- Mifamurtide (L03AX15)
- Histamine dihydrochloride (L03AX14)
- Glatiramer acetate (L03AX13)
- Melanoma vaccine (L03AX12)
- Tasonermin (L03AX11)
- Immunocyanin (L03AX10)
- Thymopentin (L03AX09)
- Poly iclc (L03AX08)
- Poly i:c (L03AX07)
- Pidotimod (L03AX05)
- Pegademase (L03AX04)
- Bcg vaccine (L03AX03)
- Roquinimex (L03AX02)
- Lentinan (L03AX01)
- Interleukins (L03AC)
- Interferons (L03AB)
- Sampeginterferon beta-1a (L03AB17)
- Peginterferon alfacon-2 (L03AB16)
- Ropeginterferon alfa-2b (L03AB15)
- Peginterferon alfa-2a, combinations (L03AB61)
- Peginterferon alfa-2b, combinations (L03AB60)
- Cepeginterferon alfa-2b (L03AB14)
- Peginterferon beta-1a (L03AB13)
- Albinterferon alfa-2b (L03AB12)
- Peginterferon alfa-2a (L03AB11)
- Peginterferon alfa-2b (L03AB10)
- Interferon alfacon-1 (L03AB09)
- Interferon beta-1b (L03AB08)
- Interferon beta-1a (L03AB07)
- Interferon alfa-n1 (L03AB06)
- Interferon alfa-2b (L03AB05)
- Interferon alfa-2a (L03AB04)
- Interferon gamma (L03AB03)
- Interferon beta natural (L03AB02)
- Interferon alfa natural (L03AB01)
- Colony stimulating factors (L03AA)
- Other immunostimulants (L03AX)
- Immunostimulants (L03A)
- Endocrine therapy (L02)
- Hormone antagonists and related agents (L02B)
- Hormones and related agents (L02A)
- Antineoplastic agents (L01)
- Monoclonal antibodies and antibody drug conjugates (L01F)
- Combinations of monoclonal antibodies and antibody drug conjugates (L01FY)
- Other monoclonal antibodies and antibody drug conjugates (L01FX)
- Talquetamab (L01FX29)
- Glofitamab (L01FX28)
- Epcoritamab (L01FX27)
- Mirvetuximab soravtansine (L01FX26)
- Mosunetuzumab (L01FX25)
- Teclistamab (L01FX24)
- Tisotumab vedotin (L01FX23)
- Loncastuximab tesirine (L01FX22)
- Naxitamab (L01FX21)
- Tremelimumab (L01FX20)
- Sabatolimab (L01FX19)
- Amivantamab (L01FX18)
- Sacituzumab govitecan (L01FX17)
- Oportuzumab monatox (L01FX16)
- Belantamab mafodotin (L01FX15)
- Polatuzumab vedotin (L01FX14)
- Enfortumab vedotin (L01FX13)
- Tafasitamab (L01FX12)
- Bermekimab (L01FX11)
- Olaratumab (L01FX10)
- Mogamulizumab (L01FX09)
- Elotuzumab (L01FX08)
- Blinatumomab (L01FX07)
- Dinutuximab beta (L01FX06)
- Brentuximab vedotin (L01FX05)
- Ipilimumab (L01FX04)
- Catumaxomab (L01FX03)
- Gemtuzumab ozogamicin (L01FX02)
- Edrecolomab (L01FX01)
- Vegf/vegfr (vascular endothelial growth factor) inhibitors (L01FG)
- Pd-1/pd-l1 (programmed cell death protein 1/death ligand 1) inhibitors (L01FF)
- Egfr (epidermal growth factor receptor) inhibitors (L01FE)
- Her2 (human epidermal growth factor receptor 2) inhibitors (L01FD)
- Cd38 (clusters of differentiation 38) inhibitors (L01FC)
- Cd22 (clusters of differentiation 22) inhibitors (L01FB)
- Cd20 (clusters of differentiation 20) inhibitors (L01FA)
- Protein kinase inhibitors (L01E)
- Other protein kinase inhibitors (L01EX)
- Capivasertib (L01EX27)
- Sitravatinib (L01EX26)
- Umbralisib (L01EX25)
- Surufatinib (L01EX24)
- Pralsetinib (L01EX23)
- Selpercatinib (L01EX22)
- Tepotinib (L01EX21)
- Ripretinib (L01EX19)
- Avapritinib (L01EX18)
- Capmatinib (L01EX17)
- Pexidartinib (L01EX15)
- Entrectinib (L01EX14)
- Gilteritinib (L01EX13)
- Larotrectinib (L01EX12)
- Quizartinib (L01EX11)
- Midostaurin (L01EX10)
- Nintedanib (L01EX09)
- Lenvatinib (L01EX08)
- Cabozantinib (L01EX07)
- Masitinib (L01EX06)
- Regorafenib (L01EX05)
- Vandetanib (L01EX04)
- Pazopanib (L01EX03)
- Sorafenib (L01EX02)
- Sunitinib (L01EX01)
- Fibroblast growth factor receptor (fgfr) tyrosine kinase inhibitors (L01EN)
- Phosphatidylinositol-3-kinase (pi3k) inhibitors (L01EM)
- Bruton's tyrosine kinase (btk) inhibitors (L01EL)
- Vascular endothelial growth factor receptor (vegfr) tyrosine kinase inhibitors (L01EK)
- Janus-associated kinase (jak) inhibitors (L01EJ)
- Human epidermal growth factor receptor 2 (her2) tyrosine kinase inhibitors (L01EH)
- Mammalian target of rapamycin (mtor) kinase inhibitors (L01EG)
- Cyclin-dependent kinase (cdk) inhibitors (L01EF)
- Mitogen-activated protein kinase (mek) inhibitors (L01EE)
- Anaplastic lymphoma kinase (alk) inhibitors (L01ED)
- B-raf serine-threonine kinase (braf) inhibitors (L01EC)
- Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors (L01EB)
- Bcr-abl tyrosine kinase inhibitors (L01EA)
- Other protein kinase inhibitors (L01EX)
- Other antineoplastic agents (L01X)
- Antineoplastic cell and gene therapy (L01XL)
- Lifileucel (L01XL11)
- Nadofaragene firadenovec (L01XL10)
- Tabelecleucel (L01XL09)
- Lisocabtagene maraleucel (L01XL08)
- Idecabtagene vicleucel (L01XL07)
- Brexucabtagene autoleucel (L01XL06)
- Ciltacabtagene autoleucel (L01XL05)
- Tisagenlecleucel (L01XL04)
- Axicabtagene ciloleucel (L01XL03)
- Talimogene laherparepvec (L01XL02)
- Sitimagene ceradenovec (L01XL01)
- Poly (adp-ribose) polymerase (parp) inhibitors (L01XK)
- Hedgehog pathway inhibitors (L01XJ)
- Histone deacetylase (hdac) inhibitors (L01XH)
- Proteasome inhibitors (L01XG)
- Retinoids for cancer treatment (L01XF)
- Combinations of antineoplastic agents (L01XY)
- Other antineoplastic agents (L01XX)
- Imetelstat (L01XX80)
- Eflornithine (L01XX79)
- Navitoclax (L01XX78)
- Adagrasib (L01XX77)
- Tebentafusp (L01XX75)
- Belzutifan (L01XX74)
- Sotorasib (L01XX73)
- Tazemetostat (L01XX72)
- Lurbinectedin (L01XX69)
- Tagraxofusp (L01XX67)
- Selinexor (L01XX66)
- Ivosidenib (L01XX62)
- Amsacrine (L01XX01)
- Asparaginase (L01XX02)
- Altretamine (L01XX03)
- Hydroxycarbamide (L01XX05)
- Lonidamine (L01XX07)
- Pentostatin (L01XX08)
- Masoprocol (L01XX10)
- Estramustine (L01XX11)
- Mitoguazone (L01XX16)
- Tiazofurine (L01XX18)
- Mitotane (L01XX23)
- Pegaspargase (L01XX24)
- Arsenic trioxide (L01XX27)
- Denileukin diftitox (L01XX29)
- Celecoxib (L01XX33)
- Anagrelide (L01XX35)
- Oblimersen (L01XX36)
- Omacetaxine mepesuccinate (L01XX40)
- Eribulin (L01XX41)
- Aflibercept (L01XX44)
- Venetoclax (L01XX52)
- Vosaroxin (L01XX53)
- Plitidepsin (L01XX57)
- Epacadostat (L01XX58)
- Enasidenib (L01XX59)
- Sensitizers used in photodynamic/radiation therapy (L01XD)
- Methylhydrazines (L01XB)
- Platinum compounds (L01XA)
- Antineoplastic cell and gene therapy (L01XL)
- Cytotoxic antibiotics and related substances (L01D)
- Other cytotoxic antibiotics (L01DC)
- Anthracyclines and related substances (L01DB)
- Actinomycines (L01DA)
- Plant alkaloids and other natural products (L01C)
- Antimetabolites (L01B)
- Pyrimidine analogues (L01BC)
- Decitabine, combinations (L01BC58)
- Floxuridine (L01BC09)
- Trifluridine, combinations (L01BC59)
- Tegafur, combinations (L01BC53)
- Fluorouracil, combinations (L01BC52)
- Decitabine (L01BC08)
- Azacitidine (L01BC07)
- Capecitabine (L01BC06)
- Gemcitabine (L01BC05)
- Carmofur (L01BC04)
- Tegafur (L01BC03)
- Fluorouracil (L01BC02)
- Cytarabine (L01BC01)
- Purine analogues (L01BB)
- Folic acid analogues (L01BA)
- Pyrimidine analogues (L01BC)
- Alkylating agents (L01A)
- Other alkylating agents (L01AX)
- Epoxides (L01AG)
- Nitrosoureas (L01AD)
- Ethylene imines (L01AC)
- Alkyl sulfonates (L01AB)
- Nitrogen mustard analogues (L01AA)
- Monoclonal antibodies and antibody drug conjugates (L01F)
- Immunosuppressants (L04)
- Musculo-skeletal system (M)
- Other drugs for disorders of the musculo-skeletal system (M09)
- Other drugs for disorders of the musculo-skeletal system (M09A)
- Other drugs for disorders of the musculo-skeletal system (M09AX)
- Delandistrogene moxeparvovec (M09AX15)
- Givinostat (M09AX14)
- Casimersen (M09AX13)
- Viltolarsen (M09AX12)
- Palovarotene (M09AX11)
- Risdiplam (M09AX10)
- Onasemnogene abeparvovec (M09AX09)
- Golodirsen (M09AX08)
- Nusinersen (M09AX07)
- Eteplirsen (M09AX06)
- Aceneuramic acid (M09AX05)
- Drisapersen (M09AX04)
- Ataluren (M09AX03)
- Chondrocytes, autologous (M09AX02)
- Hyaluronic acid (M09AX01)
- Enzymes (M09AB)
- Quinine and derivatives (M09AA)
- Other drugs for disorders of the musculo-skeletal system (M09AX)
- Other drugs for disorders of the musculo-skeletal system (M09A)
- Drugs for treatment of bone diseases (M05)
- Drugs affecting bone structure and mineralization (M05B)
- Other drugs affecting bone structure and mineralization (M05BX)
- Bone morphogenetic proteins (M05BC)
- Bisphosphonates, combinations (M05BB)
- Ibandronic acid and colecalciferol (M05BB09)
- Zoledronic acid, calcium and colecalciferol, sequential (M05BB08)
- Risedronic acid and colecalciferol (M05BB07)
- Alendronic acid and alfacalcidol, sequential (M05BB06)
- Alendronic acid, calcium and colecalciferol, sequential (M05BB05)
- Risedronic acid, calcium and colecalciferol, sequential (M05BB04)
- Alendronic acid and colecalciferol (M05BB03)
- Risedronic acid and calcium, sequential (M05BB02)
- Etidronic acid and calcium, sequential (M05BB01)
- Bisphosphonates (M05BA)
- Drugs affecting bone structure and mineralization (M05B)
- Antigout preparations (M04)
- Muscle relaxants (M03)
- Muscle relaxants, directly acting agents (M03C)
- Muscle relaxants, centrally acting agents (M03B)
- Other centrally acting agents (M03BX)
- Ethers, chemically close to antihistamines (M03BC)
- Oxazol, thiazine, and triazine derivatives (M03BB)
- Carbamic acid esters (M03BA)
- Methocarbamol, combinations with psycholeptics (M03BA73)
- Carisoprodol, combinations with psycholeptics (M03BA72)
- Phenprobamate, combinations with psycholeptics (M03BA71)
- Methocarbamol, combinations excl. psycholeptics (M03BA53)
- Carisoprodol, combinations excl. psycholeptics (M03BA52)
- Phenprobamate, combinations excl. psycholeptics (M03BA51)
- Febarbamate (M03BA05)
- Styramate (M03BA04)
- Methocarbamol (M03BA03)
- Carisoprodol (M03BA02)
- Phenprobamate (M03BA01)
- Muscle relaxants, peripherally acting agents (M03A)
- Other muscle relaxants, peripherally acting agents (M03AX)
- Other quaternary ammonium compounds (M03AC)
- Choline derivatives (M03AB)
- Curare alkaloids (M03AA)
- Topical products for joint and muscular pain (M02)
- Topical products for joint and muscular pain (M02A)
- Other topical products for joint and muscular pain (M02AX)
- Preparations with salicylic acid derivatives (M02AC)
- Capsaicin and similar agents (M02AB)
- Antiinflammatory preparations, non-steroids for topical use (M02AA)
- Loxoprofen (M02AA31)
- Esflurbiprofen (M02AA29)
- Piketoprofen (M02AA28)
- Dexketoprofen (M02AA27)
- Nimesulide (M02AA26)
- Aceclofenac (M02AA25)
- Nifenazone (M02AA24)
- Indometacin (M02AA23)
- Suxibuzone (M02AA22)
- Tolmetin (M02AA21)
- Flurbiprofen (M02AA19)
- Meclofenamic acid (M02AA18)
- Niflumic acid (M02AA17)
- Feprazone (M02AA16)
- Diclofenac (M02AA15)
- Fentiazac (M02AA14)
- Ibuprofen (M02AA13)
- Naproxen (M02AA12)
- Bendazac (M02AA11)
- Ketoprofen (M02AA10)
- Bufexamac (M02AA09)
- Felbinac (M02AA08)
- Piroxicam (M02AA07)
- Etofenamate (M02AA06)
- Benzydamine (M02AA05)
- Oxyphenbutazone (M02AA04)
- Clofezone (M02AA03)
- Mofebutazone (M02AA02)
- Phenylbutazone (M02AA01)
- Topical products for joint and muscular pain (M02A)
- Antiinflammatory and antirheumatic products (M01)
- Specific antirheumatic agents (M01C)
- Antiinflammatory/antirheumatic agents in combination (M01B)
- Antiinflammatory and antirheumatic products, non-steroids (M01A)
- Other antiinflammatory and antirheumatic agents, non-steroids (M01AX)
- Feprazone, combinations (M01AX68)
- Avocado and soyabean oil, unsaponifiables (M01AX26)
- Chondroitin sulfate (M01AX25)
- Oxaceprol (M01AX24)
- Tenidap (M01AX23)
- Morniflumate (M01AX22)
- Diacerein (M01AX21)
- Feprazone (M01AX18)
- Nimesulide (M01AX17)
- Orgotein (M01AX14)
- Proquazone (M01AX13)
- Glucosaminoglycan polysulfate (M01AX12)
- Benzydamine (M01AX07)
- Glucosamine (M01AX05)
- Azapropazone (M01AX04)
- Niflumic acid (M01AX02)
- Nabumetone (M01AX01)
- Coxibs (M01AH)
- Fenamates (M01AG)
- Propionic acid derivatives (M01AE)
- Naproxen and diphenhydramine (M01AE57)
- Naproxen and misoprostol (M01AE56)
- Ketoprofen, combinations (M01AE53)
- Naproxen and esomeprazole (M01AE52)
- Ibuprofen, combinations (M01AE51)
- Naproxcinod (M01AE18)
- Dexketoprofen (M01AE17)
- Alminoprofen (M01AE16)
- Flunoxaprofen (M01AE15)
- Dexibuprofen (M01AE14)
- Ibuproxam (M01AE13)
- Oxaprozin (M01AE12)
- Tiaprofenic acid (M01AE11)
- Indoprofen (M01AE10)
- Flurbiprofen (M01AE09)
- Pirprofen (M01AE08)
- Suprofen (M01AE07)
- Benoxaprofen (M01AE06)
- Fenbufen (M01AE05)
- Fenoprofen (M01AE04)
- Ketoprofen (M01AE03)
- Naproxen (M01AE02)
- Ibuprofen (M01AE01)
- Oxicams (M01AC)
- Acetic acid derivatives and related substances (M01AB)
- Diclofenac, combinations (M01AB55)
- Indometacin, combinations (M01AB51)
- Bufexamac (M01AB17)
- Aceclofenac (M01AB16)
- Ketorolac (M01AB15)
- Proglumetacin (M01AB14)
- Oxametacin (M01AB13)
- Difenpiramide (M01AB12)
- Acemetacin (M01AB11)
- Fentiazac (M01AB10)
- Lonazolac (M01AB09)
- Etodolac (M01AB08)
- Bumadizone (M01AB07)
- Alclofenac (M01AB06)
- Diclofenac (M01AB05)
- Zomepirac (M01AB04)
- Tolmetin (M01AB03)
- Sulindac (M01AB02)
- Indometacin (M01AB01)
- Butylpyrazolidines (M01AA)
- Other antiinflammatory and antirheumatic agents, non-steroids (M01AX)
- Other drugs for disorders of the musculo-skeletal system (M09)
- Nervous system (N)
- Other nervous system drugs (N07)
- Other nervous system drugs (N07X)
- Other nervous system drugs (N07XX)
- Troriluzole (N07XX23)
- Tofersen (N07XX22)
- Eplontersen (N07XX21)
- Sodium phenylbutyrate and ursodoxicoltaurine (N07XX19)
- Vutrisiran (N07XX18)
- Arimoclomol (N07XX17)
- Deutetrabenazine (N07XX16)
- Inotersen (N07XX15)
- Edaravone (N07XX14)
- Valbenazine (N07XX13)
- Patisiran (N07XX12)
- Dextromethorphan, combinations (N07XX59)
- Pitolisant (N07XX11)
- Laquinimod (N07XX10)
- Tafamidis (N07XX08)
- Fampridine (N07XX07)
- Tetrabenazine (N07XX06)
- Amifampridine (N07XX05)
- Sodium oxybate (N07XX04)
- Xaliproden (N07XX03)
- Riluzole (N07XX02)
- Tirilazad (N07XX01)
- Gangliosides and ganglioside derivatives (N07XA)
- Other nervous system drugs (N07XX)
- Antivertigo preparations (N07C)
- Drugs used in addictive disorders (N07B)
- Parasympathomimetics (N07A)
- Other nervous system drugs (N07X)
- Psychoanaleptics (N06)
- Anti-dementia drugs (N06D)
- Psycholeptics and psychoanaleptics in combination (N06C)
- Psychostimulants, agents used for adhd and nootropics (N06B)
- Other psychostimulants and nootropics (N06BX)
- Phenibut (N06BX22)
- Temgicoluril (N06BX21)
- Vinpocetine (N06BX18)
- Adrafinil (N06BX17)
- Pramiracetam (N06BX16)
- Pipradrol (N06BX15)
- Prolintane (N06BX14)
- Idebenone (N06BX13)
- Acetylcarnitine (N06BX12)
- Aniracetam (N06BX11)
- Nizofenone (N06BX10)
- Linopirdine (N06BX09)
- Pirisudanol (N06BX08)
- Oxiracetam (N06BX07)
- Citicoline (N06BX06)
- Fipexide (N06BX05)
- Deanol (N06BX04)
- Piracetam (N06BX03)
- Pyritinol (N06BX02)
- Meclofenoxate (N06BX01)
- Xanthine derivatives (N06BC)
- Centrally acting sympathomimetics (N06BA)
- Dexmethylphenidate and serdexmethylphenidate (N06BA15)
- Solriamfetol (N06BA14)
- Armodafinil (N06BA13)
- Lisdexamfetamine (N06BA12)
- Dexmethylphenidate (N06BA11)
- Fenetylline (N06BA10)
- Atomoxetine (N06BA09)
- Fenozolone (N06BA08)
- Modafinil (N06BA07)
- Fencamfamin (N06BA06)
- Pemoline (N06BA05)
- Methylphenidate (N06BA04)
- Metamfetamine (N06BA03)
- Dexamfetamine (N06BA02)
- Amfetamine (N06BA01)
- Other psychostimulants and nootropics (N06BX)
- Antidepressants (N06A)
- Other antidepressants (N06AX)
- Bupropion and dextromethorphan (N06AX62)
- Brexanolone (N06AX29)
- Levomilnacipran (N06AX28)
- Esketamine (N06AX27)
- Vortioxetine (N06AX26)
- Hyperici herba (N06AX25)
- Vilazodone (N06AX24)
- Desvenlafaxine (N06AX23)
- Agomelatine (N06AX22)
- Duloxetine (N06AX21)
- Gepirone (N06AX19)
- Reboxetine (N06AX18)
- Milnacipran (N06AX17)
- Venlafaxine (N06AX16)
- Pivagabine (N06AX15)
- Tianeptine (N06AX14)
- Medifoxamine (N06AX13)
- Bupropion (N06AX12)
- Mirtazapine (N06AX11)
- Oxaflozane (N06AX10)
- Viloxazine (N06AX09)
- Bifemelane (N06AX08)
- Minaprine (N06AX07)
- Nefazodone (N06AX06)
- Trazodone (N06AX05)
- Nomifensine (N06AX04)
- Mianserin (N06AX03)
- Tryptophan (N06AX02)
- Oxitriptan (N06AX01)
- Monoamine oxidase a inhibitors (N06AG)
- Monoamine oxidase inhibitors, non-selective (N06AF)
- Selective serotonin reuptake inhibitors (N06AB)
- Non-selective monoamine reuptake inhibitors (N06AA)
- Quinupramine (N06AA23)
- Maprotiline (N06AA21)
- Amineptine (N06AA19)
- Dimetacrine (N06AA18)
- Amoxapine (N06AA17)
- Dosulepin (N06AA16)
- Butriptyline (N06AA15)
- Melitracen (N06AA14)
- Iprindole (N06AA13)
- Doxepin (N06AA12)
- Protriptyline (N06AA11)
- Nortriptyline (N06AA10)
- Amitriptyline (N06AA09)
- Dibenzepin (N06AA08)
- Lofepramine (N06AA07)
- Trimipramine (N06AA06)
- Opipramol (N06AA05)
- Clomipramine (N06AA04)
- Imipramine oxide (N06AA03)
- Imipramine (N06AA02)
- Desipramine (N06AA01)
- Other antidepressants (N06AX)
- Psycholeptics (N05)
- Hypnotics and sedatives (N05C)
- Orexin receptor antagonists (N05CJ)
- Hypnotics and sedatives in combination, excl. barbiturates (N05CX)
- Other hypnotics and sedatives (N05CM)
- Dexmedetomidine (N05CM18)
- Niaprazine (N05CM16)
- Methylpentynol (N05CM15)
- Valnoctamide (N05CM13)
- Apronal (N05CM12)
- Bromides (N05CM11)
- Hexapropymate (N05CM10)
- Valerianae radix (N05CM09)
- Ethchlorvynol (N05CM08)
- Triclofos (N05CM07)
- Propiomazine (N05CM06)
- Scopolamine (N05CM05)
- Carbromal (N05CM04)
- Bromisoval (N05CM03)
- Clomethiazole (N05CM02)
- Methaqualone (N05CM01)
- Melatonin receptor agonists (N05CH)
- Benzodiazepine related drugs (N05CF)
- Piperidinedione derivatives (N05CE)
- Benzodiazepine derivatives (N05CD)
- Nimetazepam (N05CD15)
- Remimazolam (N05CD14)
- Cinolazepam (N05CD13)
- Doxefazepam (N05CD12)
- Loprazolam (N05CD11)
- Quazepam (N05CD10)
- Brotizolam (N05CD09)
- Midazolam (N05CD08)
- Temazepam (N05CD07)
- Lormetazepam (N05CD06)
- Triazolam (N05CD05)
- Estazolam (N05CD04)
- Flunitrazepam (N05CD03)
- Nitrazepam (N05CD02)
- Flurazepam (N05CD01)
- Aldehydes and derivatives (N05CC)
- Barbiturates, combinations (N05CB)
- Barbiturates, plain (N05CA)
- Proxibarbal (N05CA22)
- Allobarbital (N05CA21)
- Etallobarbital (N05CA20)
- Thiopental (N05CA19)
- Hexobarbital (N05CA16)
- Methohexital (N05CA15)
- Reposal (N05CA12)
- Heptabarbital (N05CA11)
- Cyclobarbital (N05CA10)
- Vinbarbital (N05CA09)
- Vinylbital (N05CA08)
- Talbutal (N05CA07)
- Secobarbital (N05CA06)
- Aprobarbital (N05CA05)
- Barbital (N05CA04)
- Butobarbital (N05CA03)
- Amobarbital (N05CA02)
- Pentobarbital (N05CA01)
- Anxiolytics (N05B)
- Other anxiolytics (N05BX)
- Azaspirodecanedione derivatives (N05BE)
- Dibenzo-bicyclo-octadiene derivatives (N05BD)
- Carbamates (N05BC)
- Diphenylmethane derivatives (N05BB)
- Benzodiazepine derivatives (N05BA)
- Mexazolam (N05BA25)
- Bentazepam (N05BA24)
- Lorazepam, combinations (N05BA56)
- Tofisopam (N05BA23)
- Cloxazolam (N05BA22)
- Clotiazepam (N05BA21)
- Etizolam (N05BA19)
- Ethyl loflazepate (N05BA18)
- Fludiazepam (N05BA17)
- Nordazepam (N05BA16)
- Camazepam (N05BA15)
- Pinazepam (N05BA14)
- Halazepam (N05BA13)
- Alprazolam (N05BA12)
- Prazepam (N05BA11)
- Ketazolam (N05BA10)
- Clobazam (N05BA09)
- Bromazepam (N05BA08)
- Adinazolam (N05BA07)
- Lorazepam (N05BA06)
- Potassium clorazepate (N05BA05)
- Oxazepam (N05BA04)
- Medazepam (N05BA03)
- Chlordiazepoxide (N05BA02)
- Diazepam (N05BA01)
- Antipsychotics (N05A)
- Other antipsychotics (N05AX)
- Lithium (N05AN)
- Benzamides (N05AL)
- Diazepines, oxazepines, thiazepines and oxepines (N05AH)
- Diphenylbutylpiperidine derivatives (N05AG)
- Thioxanthene derivatives (N05AF)
- Indole derivatives (N05AE)
- Butyrophenone derivatives (N05AD)
- Phenothiazines with piperidine structure (N05AC)
- Phenothiazines with piperazine structure (N05AB)
- Phenothiazines with aliphatic side-chain (N05AA)
- Hypnotics and sedatives (N05C)
- Anti-parkinson drugs (N04)
- Other antiparkinson drugs (N04C)
- Dopaminergic agents (N04B)
- Other dopaminergic agents (N04BX)
- Monoamine oxidase b inhibitors (N04BD)
- Dopamine agonists (N04BC)
- Adamantane derivatives (N04BB)
- Dopa and dopa derivatives (N04BA)
- Anticholinergic agents (N04A)
- Ethers of tropine or tropine derivatives (N04AC)
- Ethers chemically close to antihistamines (N04AB)
- Tertiary amines (N04AA)
- Antiepileptics (N03)
- Antiepileptics (N03A)
- Other antiepileptics (N03AX)
- Ganaxolone (N03AX27)
- Fenfluramine (N03AX26)
- Cenobamate (N03AX25)
- Cannabidiol (N03AX24)
- Beclamide (N03AX30)
- Brivaracetam (N03AX23)
- Perampanel (N03AX22)
- Retigabine (N03AX21)
- Carisbamate (N03AX19)
- Lacosamide (N03AX18)
- Stiripentol (N03AX17)
- Zonisamide (N03AX15)
- Levetiracetam (N03AX14)
- Pheneturide (N03AX13)
- Topiramate (N03AX11)
- Felbamate (N03AX10)
- Lamotrigine (N03AX09)
- Phenacemide (N03AX07)
- Sultiame (N03AX03)
- Fatty acid derivatives (N03AG)
- Carboxamide derivatives (N03AF)
- Benzodiazepine derivatives (N03AE)
- Succinimide derivatives (N03AD)
- Oxazolidine derivatives (N03AC)
- Hydantoin derivatives (N03AB)
- Barbiturates and derivatives (N03AA)
- Other antiepileptics (N03AX)
- Antiepileptics (N03A)
- Analgesics (N02)
- Antimigraine preparations (N02C)
- Calcitonin gene-related peptide (cgrp) antagonists (N02CD)
- Other antimigraine preparations (N02CX)
- Selective serotonin (5ht1) agonists (N02CC)
- Corticosteroid derivatives (N02CB)
- Ergot alkaloids (N02CA)
- Other analgesics and antipyretics (N02B)
- Gabapentinoids (N02BF)
- Other analgesics and antipyretics (N02BG)
- Anilides (N02BE)
- Bucetin, combinations with psycholeptics (N02BE74)
- Phenacetin, combinations with psycholeptics (N02BE73)
- Paracetamol, combinations with psycholeptics (N02BE71)
- Bucetin, combinations excl. psycholeptics (N02BE54)
- Phenacetin, combinations excl. psycholeptics (N02BE53)
- Paracetamol, combinations excl. psycholeptics (N02BE51)
- Propacetamol (N02BE05)
- Bucetin (N02BE04)
- Phenacetin (N02BE03)
- Paracetamol (N02BE01)
- Pyrazolones (N02BB)
- Propyphenazone, combinations with psycholeptics (N02BB74)
- Aminophenazone, combinations with psycholeptics (N02BB73)
- Metamizole sodium, combinations with psycholeptics (N02BB72)
- Phenazone, combinations with psycholeptics (N02BB71)
- Propyphenazone, combinations excl. psycholeptics (N02BB54)
- Aminophenazone, combinations excl. psycholeptics (N02BB53)
- Metamizole sodium, combinations excl. psycholeptics (N02BB52)
- Phenazone, combinations excl. psycholeptics (N02BB51)
- Nifenazone (N02BB05)
- Propyphenazone (N02BB04)
- Aminophenazone (N02BB03)
- Metamizole sodium (N02BB02)
- Phenazone (N02BB01)
- Salicylic acid and derivatives (N02BA)
- Magnesium salicylate, combinations excl. psycholeptics (N02BA67)
- Dipyrocetyl, combinations with psycholeptics (N02BA79)
- Ethenzamide, combinations with psycholeptics (N02BA77)
- Salicylamide, combinations with psycholeptics (N02BA75)
- Acetylsalicylic acid, combinations with psycholeptics (N02BA71)
- Carbasalate calcium combinations excl. psycholeptics (N02BA65)
- Dipyrocetyl, combinations excl. psycholeptics (N02BA59)
- Ethenzamide, combinations excl. psycholeptics (N02BA57)
- Salicylamide, combinations excl. psycholeptics (N02BA55)
- Acetylsalicylic acid, combinations excl. psycholeptics (N02BA51)
- Imidazole salicylate (N02BA16)
- Carbasalate calcium (N02BA15)
- Guacetisal (N02BA14)
- Potassium salicylate (N02BA12)
- Diflunisal (N02BA11)
- Benorilate (N02BA10)
- Dipyrocetyl (N02BA09)
- Morpholine salicylate (N02BA08)
- Ethenzamide (N02BA07)
- Salsalate (N02BA06)
- Salicylamide (N02BA05)
- Sodium salicylate (N02BA04)
- Choline salicylate (N02BA03)
- Aloxiprin (N02BA02)
- Acetylsalicylic acid (N02BA01)
- Opioids (N02A)
- Opioids in combination with non-opioid analgesics (N02AJ)
- Hydrocodone and ibuprofen (N02AJ23)
- Hydrocodone and paracetamol (N02AJ22)
- Tramadol and celecoxib (N02AJ16)
- Oxycodone and ibuprofen (N02AJ19)
- Oxycodone and acetylsalicylic acid (N02AJ18)
- Oxycodone and paracetamol (N02AJ17)
- Tramadol and other non-opioid analgesics (N02AJ15)
- Tramadol and dexketoprofen (N02AJ14)
- Tramadol and paracetamol (N02AJ13)
- Codeine and other non-opioid analgesics (N02AJ09)
- Codeine and ibuprofen (N02AJ08)
- Codeine and acetylsalicylic acid (N02AJ07)
- Codeine and paracetamol (N02AJ06)
- Dihydrocodeine and other non-opioid analgesics (N02AJ03)
- Dihydrocodeine and acetylsalicylic acid (N02AJ02)
- Dihydrocodeine and paracetamol (N02AJ01)
- Other opioids (N02AX)
- Opioids in combination with antispasmodics (N02AG)
- Morphinan derivatives (N02AF)
- Oripavine derivatives (N02AE)
- Benzomorphan derivatives (N02AD)
- Diphenylpropylamine derivatives (N02AC)
- Phenylpiperidine derivatives (N02AB)
- Natural opium alkaloids (N02AA)
- Oxymorphone (N02AA11)
- Oxycodone and naltrexone (N02AA56)
- Hydromorphone and naloxone (N02AA53)
- Codeine, combinations with psycholeptics (N02AA79)
- Codeine, combinations excl. psycholeptics (N02AA59)
- Dihydrocodeine, combinations (N02AA58)
- Oxycodone and naloxone (N02AA55)
- Morphine, combinations (N02AA51)
- Papaveretum (N02AA10)
- Dihydrocodeine (N02AA08)
- Oxycodone (N02AA05)
- Nicomorphine (N02AA04)
- Hydromorphone (N02AA03)
- Opium (N02AA02)
- Morphine (N02AA01)
- Opioids in combination with non-opioid analgesics (N02AJ)
- Antimigraine preparations (N02C)
- Anesthetics (N01)
- Anesthetics, local (N01B)
- Other local anesthetics (N01BX)
- Esters of benzoic acid (N01BC)
- Amides (N01BB)
- Bupivacaine and meloxicam (N01BB59)
- Articaine, combinations (N01BB58)
- Etidocaine, combinations (N01BB57)
- Prilocaine, combinations (N01BB54)
- Mepivacaine, combinations (N01BB53)
- Lidocaine, combinations (N01BB52)
- Bupivacaine, combinations (N01BB51)
- Combinations (N01BB20)
- Levobupivacaine (N01BB10)
- Ropivacaine (N01BB09)
- Articaine (N01BB08)
- Etidocaine (N01BB07)
- Cinchocaine (N01BB06)
- Butanilicaine (N01BB05)
- Prilocaine (N01BB04)
- Mepivacaine (N01BB03)
- Lidocaine (N01BB02)
- Bupivacaine (N01BB01)
- Esters of aminobenzoic acid (N01BA)
- Anesthetics, general (N01A)
- Other general anesthetics (N01AX)
- Opioid anesthetics (N01AH)
- Barbiturates in combination with other drugs (N01AG)
- Barbiturates, plain (N01AF)
- Halogenated hydrocarbons (N01AB)
- Ethers (N01AA)
- Anesthetics, local (N01B)
- Other nervous system drugs (N07)
- Antiparasitic products, insecticides and repellents (P)
- Ectoparasiticides, incl. scabicides, insecticides and repellents (P03)
- Insecticides and repellents (P03B)
- Ectoparasiticides, incl. scabicides (P03A)
- Anthelmintics (P02)
- Anticestodals (P02D)
- Antinematodal agents (P02C)
- Antitrematodals (P02B)
- Antiprotozoals (P01)
- Agents against leishmaniasis and trypanosomiasis (P01C)
- Antimalarials (P01B)
- Other antimalarials (P01BX)
- Artemisinin and derivatives, combinations (P01BF)
- Artesunate, sulfadoxine and pyrimethamine (P01BF09)
- Artemisinin and naphthoquine (P01BF08)
- Artemisinin and piperaquine (P01BF07)
- Artesunate and pyronaridine (P01BF06)
- Artenimol and piperaquine (P01BF05)
- Artesunate, sulfalene and pyrimethamine (P01BF04)
- Artesunate and amodiaquine (P01BF03)
- Artesunate and mefloquine (P01BF02)
- Artemether and lumefantrine (P01BF01)
- Artemisinin and derivatives, plain (P01BE)
- Diaminopyrimidines (P01BD)
- Methanolquinolines (P01BC)
- Biguanides (P01BB)
- Aminoquinolines (P01BA)
- Agents against amoebiasis and other protozoal diseases (P01A)
- Other agents against amoebiasis and other protozoal diseases (P01AX)
- Arsenic compounds (P01AR)
- Dichloroacetamide derivatives (P01AC)
- Nitroimidazole derivatives (P01AB)
- Hydroxyquinoline derivatives (P01AA)
- Ectoparasiticides, incl. scabicides, insecticides and repellents (P03)
- Respiratory system (R)
- Other respiratory system products (R07)
- Other respiratory system products (R07A)
- Other respiratory system products (R07AX)
- Respiratory stimulants (R07AB)
- Lung surfactants (R07AA)
- Other respiratory system products (R07A)
- Antihistamines for systemic use (R06)
- Antihistamines for systemic use (R06A)
- Other antihistamines for systemic use (R06AX)
- Pyrrobutamine, combinations (R06AX58)
- Thenalidine, combinations (R06AX53)
- Sequifenadine (R06AX32)
- Quifenadine (R06AX31)
- Bilastine (R06AX29)
- Rupatadine (R06AX28)
- Desloratadine (R06AX27)
- Fexofenadine (R06AX26)
- Mizolastine (R06AX25)
- Epinastine (R06AX24)
- Pimethixene (R06AX23)
- Ebastine (R06AX22)
- Tritoqualine (R06AX21)
- Azelastine (R06AX19)
- Acrivastine (R06AX18)
- Ketotifen (R06AX17)
- Deptropine (R06AX16)
- Mebhydrolin (R06AX15)
- Loratadine (R06AX13)
- Terfenadine (R06AX12)
- Astemizole (R06AX11)
- Azatadine (R06AX09)
- Pyrrobutamine (R06AX08)
- Triprolidine (R06AX07)
- Antazoline (R06AX05)
- Phenindamine (R06AX04)
- Thenalidine (R06AX03)
- Cyproheptadine (R06AX02)
- Bamipine (R06AX01)
- Combinations of antihistamines (R06AK)
- Piperazine derivatives (R06AE)
- Phenothiazine derivatives (R06AD)
- Substituted ethylene diamines (R06AC)
- Substituted alkylamines (R06AB)
- Dexbrompheniramine, combinations (R06AB56)
- Chlorphenamine, combinations (R06AB54)
- Dexchlorpheniramine, combinations (R06AB52)
- Brompheniramine, combinations (R06AB51)
- Talastine (R06AB07)
- Dexbrompheniramine (R06AB06)
- Pheniramine (R06AB05)
- Chlorphenamine (R06AB04)
- Dimetindene (R06AB03)
- Dexchlorpheniramine (R06AB02)
- Brompheniramine (R06AB01)
- Aminoalkyl ethers (R06AA)
- Dimenhydrinate, combinations (R06AA61)
- Dimenhydrinate (R06AA11)
- Doxylamine, combinations (R06AA59)
- Diphenylpyraline, combinations (R06AA57)
- Chlorphenoxamine, combinations (R06AA56)
- Clemastine, combinations (R06AA54)
- Diphenhydramine, combinations (R06AA52)
- Trimethobenzamide (R06AA10)
- Doxylamine (R06AA09)
- Carbinoxamine (R06AA08)
- Diphenylpyraline (R06AA07)
- Chlorphenoxamine (R06AA06)
- Clemastine (R06AA04)
- Diphenhydramine (R06AA02)
- Bromazine (R06AA01)
- Other antihistamines for systemic use (R06AX)
- Antihistamines for systemic use (R06A)
- Cough and cold preparations (R05)
- Other cold preparations (R05X)
- Cough suppressants and expectorants, combinations (R05F)
- Cough suppressants, excl. combinations with expectorants (R05D)
- Other cough suppressants (R05DB)
- Gefapixant (R05DB29)
- Dimethoxanate (R05DB28)
- Levodropropizine (R05DB27)
- Nepinalone (R05DB26)
- Morclofone (R05DB25)
- Tipepidine (R05DB24)
- Piperidione (R05DB23)
- Meprotixol (R05DB22)
- Cloperastine (R05DB21)
- Combinations (R05DB20)
- Dropropizine (R05DB19)
- Prenoxdiazine (R05DB18)
- Droxypropine (R05DB17)
- Dibunate (R05DB16)
- Zipeprol (R05DB15)
- Fedrilate (R05DB14)
- Butamirate (R05DB13)
- Bibenzonium bromide (R05DB12)
- Pipazetate (R05DB11)
- Clofedanol (R05DB10)
- Oxeladin (R05DB09)
- Oxolamine (R05DB07)
- Pentoxyverine (R05DB05)
- Isoaminile (R05DB04)
- Clobutinol (R05DB03)
- Benproperine (R05DB02)
- Benzonatate (R05DB01)
- Opium alkaloids and derivatives (R05DA)
- Other cough suppressants (R05DB)
- Expectorants, excl. combinations with cough suppressants (R05C)
- Mucolytics (R05CB)
- Mannitol (R05CB16)
- Erdosteine (R05CB15)
- Neltenexine (R05CB14)
- Dornase alfa (desoxyribonuclease) (R05CB13)
- Stepronin (R05CB11)
- Combinations (R05CB10)
- Letosteine (R05CB09)
- Domiodol (R05CB08)
- Sobrerol (R05CB07)
- Ambroxol (R05CB06)
- Mesna (R05CB05)
- Eprazinone (R05CB04)
- Carbocisteine (R05CB03)
- Bromhexine (R05CB02)
- Acetylcysteine (R05CB01)
- Expectorants (R05CA)
- Mucolytics (R05CB)
- Drugs for obstructive airway diseases (R03)
- Other systemic drugs for obstructive airway diseases (R03D)
- Other systemic drugs for obstructive airway diseases (R03DX)
- Leukotriene receptor antagonists (R03DC)
- Xanthines and adrenergics (R03DB)
- Xanthines (R03DA)
- Mepyramine theophyllinacetate (R03DA12)
- Theophylline, combinations with psycholeptics (R03DA74)
- Theobromine, combinations (R03DA57)
- Aminophylline, combinations (R03DA55)
- Theophylline, combinations excl. psycholeptics (R03DA54)
- Diprophylline, combinations (R03DA51)
- Combinations of xanthines (R03DA20)
- Doxofylline (R03DA11)
- Bufylline (R03DA10)
- Acefylline piperazine (R03DA09)
- Bamifylline (R03DA08)
- Theobromine (R03DA07)
- Etamiphylline (R03DA06)
- Aminophylline (R03DA05)
- Theophylline (R03DA04)
- Proxyphylline (R03DA03)
- Choline theophyllinate (R03DA02)
- Diprophylline (R03DA01)
- Adrenergics for systemic use (R03C)
- Adrenergics and other drugs for obstructive airway diseases (R03CK)
- Selective beta-2-adrenoreceptor agonists (R03CC)
- Formoterol (R03CC15)
- Clenbuterol and ambroxol (R03CC63)
- Terbutaline, combinations (R03CC53)
- Reproterol (R03CC14)
- Clenbuterol (R03CC13)
- Bambuterol (R03CC12)
- Tulobuterol (R03CC11)
- Carbuterol (R03CC10)
- Tretoquinol (R03CC09)
- Procaterol (R03CC08)
- Pirbuterol (R03CC07)
- Isoetarine (R03CC06)
- Hexoprenaline (R03CC05)
- Fenoterol (R03CC04)
- Terbutaline (R03CC03)
- Salbutamol (R03CC02)
- Non-selective beta-adrenoreceptor agonists (R03CB)
- Alpha- and beta-adrenoreceptor agonists (R03CA)
- Other drugs for obstructive airway diseases, inhalants (R03B)
- Other drugs for obstructive airway diseases, inhalants (R03BX)
- Antiallergic agents, excl. corticosteroids (R03BC)
- Anticholinergics (R03BB)
- Glucocorticoids (R03BA)
- Adrenergics, inhalants (R03A)
- Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids (R03AL)
- Indacaterol, glycopyrronium bromide and mometasone (R03AL12)
- Formoterol, glycopyrronium bromide and budesonide (R03AL11)
- Formoterol and tiotropium bromide (R03AL10)
- Formoterol, glycopyrronium bromide and beclometasone (R03AL09)
- Vilanterol, umeclidinium bromide and fluticasone furoate (R03AL08)
- Formoterol and glycopyrronium bromide (R03AL07)
- Olodaterol and tiotropium bromide (R03AL06)
- Formoterol and aclidinium bromide (R03AL05)
- Indacaterol and glycopyrronium bromide (R03AL04)
- Vilanterol and umeclidinium bromide (R03AL03)
- Salbutamol and ipratropium bromide (R03AL02)
- Fenoterol and ipratropium bromide (R03AL01)
- Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics (R03AK)
- Salbutamol and budesonide (R03AK15)
- Indacaterol and mometasone (R03AK14)
- Salbutamol and beclometasone (R03AK13)
- Salmeterol and budesonide (R03AK12)
- Formoterol and fluticasone (R03AK11)
- Vilanterol and fluticasone furoate (R03AK10)
- Formoterol and mometasone (R03AK09)
- Formoterol and beclometasone (R03AK08)
- Formoterol and budesonide (R03AK07)
- Salmeterol and fluticasone (R03AK06)
- Reproterol and sodium cromoglicate (R03AK05)
- Salbutamol and sodium cromoglicate (R03AK04)
- Isoprenaline and other drugs for obstructive airway diseases (R03AK02)
- Epinephrine and other drugs for obstructive airway diseases (R03AK01)
- Combinations of adrenergics (R03AH)
- Selective beta-2-adrenoreceptor agonists (R03AC)
- Olodaterol (R03AC19)
- Indacaterol (R03AC18)
- Bitolterol (R03AC17)
- Procaterol (R03AC16)
- Reproterol (R03AC15)
- Clenbuterol (R03AC14)
- Formoterol (R03AC13)
- Salmeterol (R03AC12)
- Tulobuterol (R03AC11)
- Carbuterol (R03AC10)
- Tretoquinol (R03AC09)
- Pirbuterol (R03AC08)
- Isoetarine (R03AC07)
- Hexoprenaline (R03AC06)
- Rimiterol (R03AC05)
- Fenoterol (R03AC04)
- Terbutaline (R03AC03)
- Salbutamol (R03AC02)
- Non-selective beta-adrenoreceptor agonists (R03AB)
- Alpha- and beta-adrenoreceptor agonists (R03AA)
- Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids (R03AL)
- Other systemic drugs for obstructive airway diseases (R03D)
- Throat preparations (R02)
- Throat preparations (R02A)
- Other throat preparations (R02AX)
- Anesthetics, local (R02AD)
- Antibiotics (R02AB)
- Antiseptics (R02AA)
- Octenidine (R02AA21)
- Various (R02AA20)
- Phenol (R02AA19)
- Hexamidine (R02AA18)
- Cetrimonium (R02AA17)
- Benzalkonium (R02AA16)
- Povidone-iodine (R02AA15)
- Oxyquinoline (R02AA14)
- Acriflavinium chloride (R02AA13)
- Hexylresorcinol (R02AA12)
- Chlorquinaldol (R02AA11)
- Myristyl-benzalkonium (R02AA10)
- Benzethonium (R02AA09)
- Cetylpyridinium (R02AA06)
- Chlorhexidine (R02AA05)
- Dichlorobenzyl alcohol (R02AA03)
- Dequalinium (R02AA02)
- Ambazone (R02AA01)
- Throat preparations (R02A)
- Nasal preparations (R01)
- Nasal decongestants for systemic use (R01B)
- Decongestants and other nasal preparations for topical use (R01A)
- Other nasal preparations (R01AX)
- Corticosteroids (R01AD)
- Mometasone, combinations (R01AD59)
- Hydrocortisone, combinations (R01AD60)
- Fluticasone, combinations (R01AD58)
- Tixocortol, combinations (R01AD57)
- Dexamethasone, combinations (R01AD53)
- Prednisolone, combinations (R01AD52)
- Ciclesonide (R01AD13)
- Fluticasone furoate (R01AD12)
- Triamcinolone (R01AD11)
- Mometasone (R01AD09)
- Fluticasone (R01AD08)
- Tixocortol (R01AD07)
- Betamethasone (R01AD06)
- Budesonide (R01AD05)
- Flunisolide (R01AD04)
- Dexamethasone (R01AD03)
- Prednisolone (R01AD02)
- Beclometasone (R01AD01)
- Antiallergic agents, excl. corticosteroids (R01AC)
- Sympathomimetics, combinations excl. corticosteroids (R01AB)
- Sympathomimetics, plain (R01AA)
- Indanazoline (R01AA15)
- Epinephrine (R01AA14)
- Tymazoline (R01AA13)
- Fenoxazoline (R01AA12)
- Tuaminoheptane (R01AA11)
- Metizoline (R01AA10)
- Tramazoline (R01AA09)
- Naphazoline (R01AA08)
- Xylometazoline (R01AA07)
- Tetryzoline (R01AA06)
- Oxymetazoline (R01AA05)
- Phenylephrine (R01AA04)
- Ephedrine (R01AA03)
- Cyclopentamine (R01AA02)
- Other respiratory system products (R07)
- Sensory organs (S)
- Ophthalmological and otological preparations (S03)
- Otologicals (S02)
- Ophthalmologicals (S01)
- Other ophthalmologicals (S01X)
- Ocular vascular disorder agents (S01L)
- Surgical aids (S01K)
- Diagnostic agents (S01J)
- Local anesthetics (S01H)
- Decongestants and antiallergics (S01G)
- Mydriatics and cycloplegics (S01F)
- Antiglaucoma preparations and miotics (S01E)
- Antiinflammatory agents and antiinfectives in combination (S01C)
- Antiinflammatory agents (S01B)
- Antiinfectives (S01A)
- Various (V)
- Surgical dressings (V20)
- Therapeutic radiopharmaceuticals (V10)
- Diagnostic radiopharmaceuticals (V09)
- Other diagnostic radiopharmaceuticals (V09X)
- Tumour detection (V09I)
- Other diagnostic radiopharmaceuticals for tumour detection (V09IX)
- Psma-1007 (18f) (V09IX17)
- Piflufolastat (18f) (V09IX16)
- Copper (64cu) dotatate (V09IX15)
- Gallium (68ga) gozetotide (V09IX14)
- Methionine (11c) (V09IX13)
- Fluciclovine (18f) (V09IX12)
- Fluoroestradiol (18f) (V09IX11)
- Fluoroethyl-l-tyrosine (18f) (V09IX10)
- Gallium (68ga) edotreotide (V09IX09)
- Fluoroethylcholine (18f) (V09IX08)
- Fluorocholine (18f) (V09IX07)
- Sodium fluoride (18f) (V09IX06)
- Fluorodopa (18f) (V09IX05)
- Fludeoxyglucose (18f) (V09IX04)
- Iodine (125i) cc49-monoclonal antibody (V09IX03)
- Iobenguane (131i) (V09IX02)
- Iobenguane (123i) (V09IX01)
- Indium (111in) compounds (V09IB)
- Technetium (99mtc) compounds (V09IA)
- Technetium (99mtc)trofolastat chloride (V09IA10)
- Technetium (99mtc) tilmanocept (V09IA09)
- Technetium (99mtc) etarfolatide (V09IA08)
- Technetium (99mtc) hynic-octreotide (V09IA07)
- Technetium (99mtc) arcitumomab (V09IA06)
- Technetium (99mtc) depreotide (V09IA05)
- Technetium (99mtc) votumumab (V09IA04)
- Technetium (99mtc) pentavalent succimer (V09IA03)
- Technetium (99mtc) antimelanoma antibody (V09IA02)
- Technetium (99mtc) anticarcinoembryonicantigen antibody (V09IA01)
- Other diagnostic radiopharmaceuticals for tumour detection (V09IX)
- Inflammation and infection detection (V09H)
- Cardiovascular system (V09G)
- Other cardiovascular system diagnostic radiopharmaceuticals (V09GX)
- Iodine (125i) compounds (V09GB)
- Technetium (99mtc) compounds (V09GA)
- Thyroid (V09F)
- Respiratory system (V09E)
- Hepatic and reticulo endothelial system (V09D)
- Other hepatic and reticulo endothelial system diagnostic radiopharmaceuticals (V09DX)
- Technetium (99mtc), particles and colloids (V09DB)
- Technetium (99mtc) compounds (V09DA)
- Renal system (V09C)
- Skeleton (V09B)
- Central nervous system (V09A)
- Other central nervous system diagnostic radiopharmaceuticals (V09AX)
- Iodine (123i) compounds (V09AB)
- Technetium (99mtc) compounds (V09AA)
- Contrast media (V08)
- Ultrasound contrast media (V08D)
- Magnetic resonance imaging contrast media (V08C)
- Other magnetic resonance imaging contrast media (V08CX)
- Superparamagnetic contrast media (V08CB)
- Paramagnetic contrast media (V08CA)
- X-ray contrast media, non-iodinated (V08B)
- X-ray contrast media, iodinated (V08A)
- Non-watersoluble x-ray contrast media (V08AD)
- Watersoluble, hepatotropic x-ray contrast media (V08AC)
- Watersoluble, nephrotropic, low osmolar x-ray contrast media (V08AB)
- Watersoluble, nephrotropic, high osmolar x-ray contrast media (V08AA)
- All other non-therapeutic products (V07)
- All other non-therapeutic products (V07A)
- Chemicals and reagents for analysis (V07AZ)
- Other non-therapeutic auxiliary products (V07AY)
- Washing agents etc. (V07AX)
- Technical disinfectants (V07AV)
- Cosmetics (V07AT)
- Stomi equipment (V07AS)
- Sensitivity tests, discs and tablets (V07AR)
- Incontinence equipment (V07AN)
- Blood tests, auxiliary products (V07AD)
- Blood transfusion, auxiliary products (V07AC)
- Solvents and diluting agents, incl. irrigating solutions (V07AB)
- Plasters (V07AA)
- All other non-therapeutic products (V07A)
- General nutrients (V06)
- Other nutrients (V06D)
- Other combinations of nutrients (V06DX)
- Milk substitutes (V06DF)
- Amino acids/carbohydrates/minerals/vitamins, combinations (V06DE)
- Amino acids, incl. combinations with polypeptides (V06DD)
- Carbohydrates (V06DC)
- Fat/carbohydrates/proteins/minerals/vitamins, combinations (V06DB)
- Carbohydrates/proteins/minerals/vitamins, combinations (V06DA)
- Infant formulas (V06C)
- Protein supplements (V06B)
- Diet formulations for treatment of obesity (V06A)
- Other nutrients (V06D)
- Diagnostic agents (V04)
- Other diagnostic agents (V04C)
- Other diagnostic agents (V04CX)
- Tests for fertility disturbances (V04CM)
- Tests for allergic diseases (V04CL)
- Tests for pancreatic function (V04CK)
- Tests for thyreoidea function (V04CJ)
- Tests for renal function and ureteral injuries (V04CH)
- Tests for gastric secretion (V04CG)
- Tuberculosis diagnostics (V04CF)
- Tests for liver functional capacity (V04CE)
- Tests for pituitary function (V04CD)
- Tests for bile duct patency (V04CC)
- Tests for fat absorption (V04CB)
- Tests for diabetes (V04CA)
- Urine tests (V04B)
- Other diagnostic agents (V04C)
- All other therapeutic products (V03)
- All other therapeutic products (V03A)
- Nerve depressants (V03AZ)
- Other therapeutic products (V03AX)
- Medical gases (V03AN)
- Drugs for embolisation (V03AM)
- Tissue adhesives (V03AK)
- Drugs for treatment of hypoglycemia (V03AH)
- Drugs for treatment of hypercalcemia (V03AG)
- Detoxifying agents for antineoplastic treatment (V03AF)
- Drugs for treatment of hyperkalemia and hyperphosphatemia (V03AE)
- Iron chelating agents (V03AC)
- Antidotes (V03AB)
- Pralidoxime and atropine (V03AB54)
- Andexanet alfa (V03AB38)
- Idarucizumab (V03AB37)
- Phentolamine (V03AB36)
- Sugammadex (V03AB35)
- Fomepizole (V03AB34)
- Hydroxocobalamin (V03AB33)
- Glutathione (V03AB32)
- Prussian blue (V03AB31)
- Cholinesterase (V03AB29)
- 4-dimethylaminophenol (V03AB27)
- Methionine (V03AB26)
- Flumazenil (V03AB25)
- Digitalis antitoxin (V03AB24)
- Acetylcysteine (V03AB23)
- Amyl nitrite (V03AB22)
- Potassium iodide (V03AB21)
- Copper sulfate (V03AB20)
- Physostigmine (V03AB19)
- Potassium permanganate (V03AB18)
- Methylthioninium chloride (V03AB17)
- Ethanol (V03AB16)
- Naloxone (V03AB15)
- Protamine (V03AB14)
- Obidoxime (V03AB13)
- Dimercaprol (V03AB09)
- Sodium nitrite (V03AB08)
- Thiosulfate (V03AB06)
- Prednisolone and promethazine (V03AB05)
- Pralidoxime (V03AB04)
- Edetates (V03AB03)
- Nalorphine (V03AB02)
- Ipecacuanha (V03AB01)
- All other therapeutic products (V03A)
- Allergens (V01)